Alcentra Capital Earnings 2019-06-30

ABDC 10Q Quarterly Report

Balance Sheet	Income Statement	Cash Flow

10-Q 1 tv526738_10q.htm FORM 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2019

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

COMMISSION FILE NUMBER: 1-36447

ALCENTRA CAPITAL CORPORATION

(Exact Name of Registrant as Specified in Its Charter)

Maryland	46-2961489
(State or other Jurisdiction of Incorporation or Organization)	(I.R.S. Employer Identification No.)

200 Park Avenue, 7 ^th Floor
New York, NY	10166
(Address of Principal Executive Offices)	(Zip Code)

(212) 922-8240

(Registrant’s Telephone Number, Including Area Code)

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class	Trading Symbol	Name of Each Exchange on Which Registered
Common Stock, par value $0.001 per share	ABDC	The NASDAQ Global Select Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ¨ No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer	¨	Accelerated filer	x

Non-accelerated filer	¨	Smaller reporting company	¨

Emerging growth company	x

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. x

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x

There were 12,875,566 shares of the Registrant’s common stock outstanding as of August 7, 2019.

ALCENTRA CAPITAL CORPORATION

TABLE OF CONTENTS

	Page

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

Consolidated Financial Statements of Alcentra Capital Corporation:

Consolidated Statements of Assets and Liabilities as of June 30, 2019 (unaudited) and December 31, 2018	3

Consolidated Statements of Operations for the Three and Six Months Ended June 30, 2019 (unaudited) and 2018 (unaudited)	4

Consolidated Statements of Changes in Net Assets for the Three and Six Months Ended June 30, 2019 (unaudited) and 2018 (unaudited)	5

Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2019 (unaudited) and 2018 (unaudited)	7

Consolidated Schedule of Investments as of June 30, 2019 (unaudited) and December 31, 2018	8

Notes to Unaudited Consolidated Financial Statements	16

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	33

Item 3. Quantitative and Qualitative Disclosures About Market Risk	41

Item 4. Controls and Procedures	41

PART II. OTHER INFORMATION	42

Item 1. Legal Proceedings	42

Item 1A. Risk Factors	42

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	43

Item 3. Defaults Upon Senior Securities	44

Item 4. Mine Safety Disclosures	44

Item 5. Other Information	44

Item 6. Exhibits	44

SIGNATURES	45

Alcentra Capital Corporation and Subsidiary

Consolidated Statements of Assets and Liabilities

	As of June 30, 2019 (Unaudited)			As of December 31, 2018
Assets
Portfolio investments, at fair value
Non-controlled, non-affiliated investments, at fair value (cost of $213,022,113 and $212,280,172, respectively)	$	204,633,762		$	205,411,779
Non-controlled, affiliated investments, at fair value (cost of $26,581,387 and $26,385,612, respectively)		14,573,438			12,980,016
Controlled, affiliated investments, at fair value (cost $0 and $15,212,562, respectively)		—			16,406,021
Cash		7,796,536			11,049,499
Dividends and interest receivable		1,404,187			454,883
Receivable for investments sold		2,674,457			644,733
Deferred financing costs		1,066,348			1,366,393
Deferred tax asset		4,263,462			5,385,694
Prepaid expenses and other assets		354,583			79,410
Total Assets	$	236,766,773		$	253,778,428

Liabilities
Credit facility payable	$	26,565,008		$	28,536,441
Notes payable (net of deferred note offering costs of $642,731 and $855,433, respectively)		54,357,269			54,144,567
Payable for investments purchased		5,925,000			18,550,000
Other accrued expenses and liabilities		251,183			535,096
Directors’ fees payable		197,154			36,125
Professional fees payable		886,641			554,173
Interest and credit facility expense payable		1,176,846			1,069,139
Management fee payable		701,305			765,659
Income-based incentive fees payable		198,805			890,796
Distributions payable		4,248,937			2,433,102
Unearned structuring fee revenue		—			81,643
Income tax liability		320,630			379,155
Total Liabilities		94,828,778			107,975,896

Commitments and Contingencies (Note 12)

Net Assets
Common stock, par value $0.001 per share (100,000,000 shares authorized, 12,875,566 and 13,105,295 shares issued and outstanding, respectively)		12,876			13,105
Additional paid-in capital		197,118,476			198,594,662
Distributable earnings (accumulated loss)		(55,193,357	)		(52,805,235	)
Total Net Assets		141,937,995			145,802,532
Total Liabilities and Net Assets	$	236,766,773		$	253,778,428

Net Asset Value Per Share	$	11.02		$	11.13

See notes to unaudited consolidated financial statements

Alcentra Capital Corporation and Subsidiary

Consolidated Statements of Operations

	For the three months ended June 30, 2019 (Unaudited)			For the three months ended June 30, 2018 (Unaudited)			For the six months ended June 30, 2019 (Unaudited)			For the six months ended June 30, 2018 (Unaudited)
Investment Income:
From non-controlled, non-affiliated investments:
Interest income from portfolio investments	$	5,753,089		$	5,865,711		$	11,559,398		$	11,608,097
Paid-in-kind interest income from portfolio investments		28,797			45,481			113,301			245,131
Other income from portfolio investments		177,118			611,812			284,875			2,119,116
Dividend income from portfolio investments		—			30,756			—			61,512
From non-controlled, affiliated investments:
Interest income from portfolio investments		41,762			129,080			78,241			206,533
Paid in-kind income from portfolio investments		93,190			90,004			189,603			213,130
Other income from portfolio investments		—			—			—			—
From controlled, affiliated investments:
Interest income from portfolio investments		—			481,106			208,538			981,996
Paid in-kind income from portfolio investments		—			—			—			—
Other income from portfolio investments		45,979			—			133,095			—
Total investment income		6,139,935			7,253,950			12,567,051			15,435,515

Expenses:
Management fees		841,566			1,036,122			1,707,184			2,270,985
Income-based incentive fees/(reversal of accruals)		(204,867	)		—			(691,991	)		—
Professional fees		774,386			379,082			1,399,615			733,152
Valuation services		86,250			(10,038	)		157,500			53,933
Interest and credit facility expense		1,322,878			1,745,485			2,740,328			3,440,372
Amortization of deferred financing costs		206,429			103,570			412,545			207,551
Directors’ fees		215,000			116,826			374,676			213,028
Insurance expense		91,492			56,519			147,327			112,507
Amortization of deferred note offering costs		109,340			119,267			242,703			245,961
Consulting fees		133,315			176,702			244,916			481,740
Excise tax		(78,019	)		365,308			390,413			365,308
Other expenses		251,851			(209,200	)		314,299			160,511
Total expenses		3,749,621			3,879,643			7,439,515			8,285,048
Waiver of management fees		(140,261	)		(109,281	)		(284,531	)		(109,281	)
Net expenses		3,609,360			3,770,362			7,154,984			8,175,767
Net investment income and foreign currency transactions		2,530,575			3,483,588			5,412,067			7,259,748

Realized Gain (Loss) and Net Change in Unrealized Appreciation (Depreciation) From Portfolio Investments
Net realized gain (loss) on:
Non-controlled, non-affiliated investments		1,604,042			(10,108,277	)		(111,717	)		(10,123,092	)
Non-controlled, affiliated investments		—			(10,167,517	)		—			(10,167,517	)
Controlled, affiliated investments		—			—			1,193,459			—
Foreign currency transactions		25,078			—			65,494			—
Net realized gain (loss) from portfolio investments and foreign currency transactions		1,629,120			(20,275,794	)		1,147,236			(20,290,609	)
Net change in unrealized appreciation (depreciation) on:
Non-controlled, non-affiliated investments		(1,339,551	)		4,213,571			(1,519,958	)		3,880,145
Non-controlled, affiliated investments		324,231			9,319,907			1,397,647			9,212,533
Controlled, affiliated investments		—			—			(1,193,459	)		220,904
Foreign currency translation		(127,563	)		—			(11,628	)		—
Net change in unrealized appreciation (depreciation) from portfolio investments and foreign currency translation		(1,142,883	)		13,533,478			(1,327,398	)		13,313,582
Benefit (Provision) for income taxes on unrealized gain (loss) on investments		(871,877	)		1,019,717			(1,124,675	)		1,017,228
Net realized gain (loss) and net change in unrealized appreciation (depreciation) from portfolio investments		(385,640	)		(5,722,599	)		(1,304,837	)		(5,959,799	)
Net Increase (Decrease) in Net Assets Resulting from Operations	$	2,144,935		$	(2,239,011	)	$	4,107,230		$	1,299,949

Basic and diluted:
Net investment income per share	$	0.20		$	0.25		$	0.42		$	0.52
Earnings (loss) per share	$	0.17		$	(0.16	)	$	0.32		$	0.09
Weighted Average Shares of Common Stock Outstanding		12,875,566			13,725,423			12,890,887			13,960,729

See notes to unaudited consolidated financial statements

Alcentra Capital Corporation and Subsidiary

Consolidated Statements of Changes in Net Assets

(Unaudited)

	Common Stock
	Shares			Par Amount			Paid in Capital in Excess of Par			Distributable Earnings			Total Net Assets
Balance at March 31, 2018		14,010,374		$	14,010		$	205,060,309		$	(47,891,919	)	$	157,182,400
Increase (decrease) in net assets resulting from operations
Net investment income		—			—			—			3,483,588			3,483,588
Net realized gain (loss) on investments and foreign currency transactions		—			—			—			(20,275,794	)		(20,275,794	)
Net change in unrealized appreciation/(depreciation) on investments and foreign currency translation		—			—			—			13,533,478			13,533,478
Benefit (Provision) for income taxes on unrealized gain (loss) on investments		—			—			—			1,019,717			1,019,717
Shareholder distributions:
Repurchase of common stock		(427,623	)		(427	)		(2,898,627	)		—			(2,899,054	)
Distributions to shareholders		—			—			—			(2,449,591	)		(2,449,591	)
Total increase (decrease) for the three months ended June 30, 2018		(427,623	)		(427	)		(2,898,627	)		(4,688,602	)		(7,587,656	)
Balance at June 30, 2018		13,582,751		$	13,583		$	202,161,682		$	(52,580,521	)	$	149,594,744
Dividends declared per common share		—		$	—		$	—		$	0.18		$	0.18

Balance at December 31, 2017		14,222,945		$	14,223		$	206,570,701		$	(48,870,749	)	$	157,714,175
Increase (decrease) in net assets resulting from operations
Net investment income		—			—			—			7,259,748			7,259,748
Net realized gain (loss) on investments and foreign currency transactions		—			—			—			(20,290,609	)		(20,290,609	)
Net change in unrealized appreciation/(depreciation) on investments and foreign currency translation		—			—			—			13,313,582			13,313,582
Benefit (Provision) for income taxes on unrealized gain (loss) on investments		—			—			—			1,017,228			1,017,228
Shareholder distributions:
Repurchase of common stock		(640,194	)		(640	)		(4,409,019	)		—			(4,409,659	)
Distributions to shareholders		—			—			—			(5,009,721	)		(5,009,721	)
Total increase (decrease) for the six months ended June 30, 2018		(640,194	)		(640	)		(4,409,019	)		(3,709,772	)		(8,119,431	)
Balance at June 30, 2018		13,582,751		$	13,583		$	202,161,682		$	(52,580,521	)	$	149,594,744
Dividends declared per common share		—		$	—		$	—		$	0.36		$	0.36

See notes to unaudited consolidated financial statements

Alcentra Capital Corporation and Subsidiary

Consolidated Statements of Changes in Net Assets

(Unaudited)

	Common Stock
	Shares			Par Amount			Paid in Capital in Excess of Par			Distributable Earnings			Total Net Assets
Balance at March 31, 2019		12,875,566		$	12,876		$	197,118,476		$	(53,276,042	)	$	143,855,310
Increase (decrease) in net assets resulting from operations
Net investment income		—			—			—			2,530,575			2,530,575
Net realized gain (loss) on investments and foreign currency transactions		—			—			—			1,629,120			1,629,120
Net change in unrealized appreciation/(depreciation) on investments and foreign currency translation		—			—			—			(1,142,883	)		(1,142,883	)
Benefit (Provision) for income taxes on unrealized gain (loss) on investments		—			—			—			(871,877	)		(871,877	)
Shareholder distributions:
Repurchase of common stock		—			—			—			—			—
Distributions to shareholders		—			—			—			(4,062,250	)		(4,062,250	)
Total increase (decrease) for the three months ended June 30, 2019		—			—			—			(1,917,315	)		(1,917,315	)
Balance at June 30, 2019		12,875,566		$	12,876		$	197,118,476		$	(55,193,357	)	$	141,937,995
Dividends declared per common share		—		$	—		$	—		$	0.33		$	0.33

Balance at December 31, 2018		13,105,295		$	13,105		$	198,594,662		$	(52,805,235	)	$	145,802,532
Increase (decrease) in net assets resulting from operations
Net investment income		—			—			—			5,412,067			5,412,067
Net realized gain (loss) on investments and foreign currency transactions		—			—			—			1,147,236			1,147,236
Net change in unrealized appreciation/(depreciation) on investments and foreign currency translation		—			—			—			(1,327,398	)		(1,327,398	)
Benefit (Provision) for income taxes on unrealized gain (loss) on investments		—			—			—			(1,124,675	)		(1,124,675	)
Shareholder distributions:
Repurchase of common stock		(229,729	)		(229	)		(1,476,186	)		—			(1,476,415	)
Distributions to shareholders		—			—			—			(6,495,352	)		(6,495,352	)
Total increase (decrease) for the six months ended June 30, 2019		(229,729	)		(229	)		(1,476,186	)		(2,388,122	)		(3,864,537	)
Balance at June 30, 2019		12,875,566		$	12,876		$	197,118,476		$	(55,193,357	)	$	141,937,995
Dividends declared per common share		—		$	—		$	—		$	0.51		$	0.51

See notes to unaudited consolidated financial statements

Alcentra Capital Corporation and Subsidiary

Consolidated Statements of Cash Flows

	For the six months ended June 30, 2019 (Unaudited)			For the six months ended June 30, 2018 (Unaudited)
Cash Flows from Operating Activities
Net increase/(decrease) in net assets resulting from operations	$	4,107,230		$	1,299,949

Adjustments to reconcile net increase/(decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:
Net realized (gain) loss from portfolio investments		(1,081,742	)		20,290,609
Net change in unrealized (appreciation) depreciation of portfolio investments		1,315,770			(13,313,582	)
Deferred tax asset		1,122,232			(1,020,150	)
Paid in-kind interest income from portfolio investments		(302,904	)		(458,261	)
Accretion of discount on debt securities		(998,069	)		(342,245	)
Purchases of portfolio investments		(58,735,969	)		(44,048,803	)
Net proceeds from sales/return of capital of portfolio investments		75,393,530			79,266,967
Amortization of deferred financing costs		412,545			207,551
Amortization of deferred note offering costs		242,703			245,961
(Increase) decrease in operating assets:
Dividends and interest receivable		(949,304	)		(772,871	)
Receivable for investments sold		(2,029,724	)		—
Income tax asset		—			104,089
Prepaid expenses and other assets		(275,173	)		(129,557	)
Increase (decrease) in operating liabilities:
Payable for investments purchased		(12,625,000	)		—
Other accrued expenses and liabilities		(283,913	)		76,131
Directors' fees payable		161,029			(32,792	)
Professional fees payable		332,468			94,867
Interest and credit facility expense payable		107,707			(90,618	)
Management fee payable		(64,354	)		(338,331	)
Income-based incentive fees payable		(691,991	)		—
Unearned structuring fee revenue		(81,643	)		(393,973	)
Income tax liability		(58,525	)		—
Net cash provided by (used in) operating activities		5,016,903			40,644,941

Cash Flows from Financing Activities
Financing costs paid		(112,500	)		(112,501	)
Offering costs paid		(30,001	)		(30,001	)
Proceeds from credit facility payable		51,606,335			21,350,000
Repayments of credit facility payable		(53,564,218	)		(52,500,000	)
Distributions paid to shareholders		(4,679,517	)		(6,121,435	)
Repurchase of common stock		(1,476,415	)		(4,409,659	)
Net cash provided by (used in) financing activities		(8,256,316	)		(41,823,596	)
Effect of exchange rate changes on cash denominated in foreign currency		(13,550	)		—
Increase (decrease) in cash and cash equivalents		(3,252,963	)		(1,178,655	)
Cash at beginning of period		11,049,499			13,882,956
Cash and Cash Equivalents at End of Period	$	7,796,536		$	12,704,301

Supplemental and non-cash financing activities:
Cash paid during the period for interest	$	2,632,621		$	3,530,990
Accrued offering costs	$	2,485		$	2,485
Accrued distributions payable	$	4,248,937		$	2,449,591

See notes to unaudited consolidated financial statements

Alcentra Capital Corporation and Subsidiary

Consolidated Schedule of Investments

As of June 30, 2019

(Unaudited)

Company(+) ***	Industry	Spread Above Index	Base Rate Floor			Interest Rate			Maturity Date	No. Shares/ Principal Amount		Cost⁽¹⁾		Fair Value		% of Net Assets
Investments in Non-Controlled, Non-Affiliated Portfolio Companies — 144.17%
Senior Secured - First Lien — 95.48%
Aegis Sciences Corporation ^(2),(3)	Consumer Services	LIBOR + 5.50%		1.00	%		8.24	%	5/9/2025		7,441,263	$	7,280,818	$	7,162,215		5.05	%
Black Diamond Oilfield Rentals, LLC ^(2),(4)	Oil & Gas Services	LIBOR + 6.50%		1.00	%		9.09	%	12/17/2020		10,955,419		10,955,419		10,955,419		7.72	%
Cambium Learning Group, Inc. ^(2),(4)	Technology & Telecom	LIBOR + 4.50%					7.08	%	12/18/2025		1,985,013		1,891,781		1,957,718		1.38	%
CGGR Operations Holdings Corporation ^(2),(4),(11)	Business Services	LIBOR + 7.0%		1.00	%		9.59	%	9/30/2022		3,136,418		3,108,892		3,136,418		2.21	%
Clanwilliam Group Ltd. ^(2),(4),(5)	Technology & Telecom	Euribor + 7.00%					7.00	%	11/8/2025	€	5,922,000		6,570,730		6,559,381		4.62	%
Digital Room Holdings, Inc. ^(2),(4)	Business Services	LIBOR + 5.00%					7.52	%	5/21/2026		7,000,000		6,895,000		6,895,950		4.86	%
Envocore Holding, LLC ^(2),(4),(6)	Industrial Services	LIBOR + 10.25%		1.00	%		12.85	%	6/30/2022		17,694,444		17,656,113		16,101,944		11.34	%
Epic Healthcare Staffing Intermediate Holdco, LLC ^{(2),(4),(5),(7)}	Business Services	LIBOR + 8.25%		1.00	%		10.84	%	10/19/2022		10,840,396		10,807,734		10,840,395		7.64	%
GGC Aperio Holdings, L.P. ^(2),(4)	Financial Services	LIBOR + 5.00%					7.59	%	10/26/2024		8,662,500		8,244,193		8,619,188		6.07	%
Healthcare Associates of Texas, LLC ^(2),(4),(5)	Healthcare Services	LIBOR + 8.25%		1.00	%		10.84	%	11/8/2022		20,445,329		20,445,328		20,445,329		14.40	%
Impact Group, LLC ^(2),(4)	Consumer Services	LIBOR + 6.50%		1.00	%		9.10	%	6/27/2023		13,905,486		13,858,297		13,523,085		9.53	%
Institutional Shareholder Services, Inc. ^(2),(4)	Business Services	LIBOR + 4.50%					7.10	%	3/5/2026		2,992,500		2,963,796		2,963,809		2.09	%
Manna Pro Products, LLC ^(2),(4),(5)	Consumer Services	LIBOR + 6.00%		1.00	%		8.44	%	12/8/2023		7,404,645		7,328,732		7,330,600		5.16	%
Palmetto Moon LLC ⁽⁴⁾	Retail	11.5% Cash, 2.5% PIK					14.00	%	10/31/2021		4,397,117		4,382,769		4,265,203		3.00	%
Perforce Software Inc. ^(2),(4)	High Tech Industries	LIBOR + 4.50%					6.82	%	7/1/2026		5,000,000		4,975,000		4,975,000		3.51	%
Pinstripe Holdings, LLC ^(2),(4)	Business Services	LIBOR + 6.00%					8.44	%	1/17/2025		9,975,000		9,789,167		9,792,500		6.90	%
Total Senior Secured - First Lien													137,153,769		135,524,154		95.48	%

Senior Secured - Second Lien — 45.96%

BayMark Health Services, Inc. ^(2),(4),(5)	Healthcare Services	LIBOR + 8.25%		1.00	%		10.77	%	3/1/2025		8,000,000	$	7,893,042	$	8,000,000		5.64	%

See notes to unaudited consolidated financial statements

Alcentra Capital Corporation and Subsidiary

Consolidated Schedule of Investments (continued)

As of June 30, 2019

(Unaudited)

Company(+) ***	Industry	Spread Above Index	Base Rate Floor			Interest Rate			Maturity Date	No. Shares/ Principal Amount		Cost⁽¹⁾		Fair Value		% of Net Assets
Cambium Learning Group, Inc. ^(2),(4)	Technology & Telecom	LIBOR + 8.50%					11.08	%	12/18/2026		5,000,000	$	4,710,240	$	4,716,118		3.32	%
CGGR Operations Holdings Corporation ^(2),(4),(11)	Business Services	LIBOR + 11.5%		1.00	%		14.09	%	9/30/2023		11,431,579		11,349,077		11,431,578		8.05	%
Institutional Shareholder Services, Inc. ^(2),(4)	Business Services	LIBOR + 8.50%					11.12	%	3/5/2027		2,000,000		1,942,261		1,942,302		1.37	%
Medsurant Holdings, LLC ⁽⁴⁾	High Tech Industries	13.00% Cash					13.00	%	6/30/2020		8,729,396		8,710,483		8,729,396		6.15	%
Perforce Software Inc. ^(2),(4)	High Tech Industries	LIBOR + 8.00%					10.32	%	7/1/2027		5,000,000		4,850,000		4,950,000		3.49	%
Pharmalogic Holdings Corp. ^(2),(4)	Healthcare Services	LIBOR + 8.0%					10.44	%	12/11/2023		16,100,000		16,034,637		16,100,000		11.34	%
Sandvine Corporation ^(2),(4)	Telecommunications	LIBOR + 8.00%					10.44	%	11/2/2026		4,500,000		4,414,967		4,417,330		3.11	%
WeddingWire, Inc. ^(2),(4)	Consumer Services	LIBOR + 8.25%					10.69	%	12/21/2026		5,000,000		4,952,134		4,952,896		3.49	%
Total Senior Secured - Second Lien													64,856,841		65,239,620		45.96	%
CLO/Structured Credit — 1.29%
Goldentree Loan Management US CLO 2 Ltd. ^(2),(3)	USD CLO	LIBOR + 4.70%					7.06	%	11/28/2030		2,000,000	$	1,949,886	$	1,828,490		1.29	%
Total CLO/Structured Credit													1,949,886		1,828,490		1.29	%
Equity/Other — 1.44%

Envocore Holding, LLC, Preferred Shares^(4),(6),(8)	Industrial Services										1,139,725	$	1,160,360	$	—		—
IGT, Preferred Shares^(4),(8)	Industrial Services	11% PIK					11.00	%	12/10/2024		1,110,922		1,110,922		—		—
Common Shares^(4),(8)											44,000		44,000		—		—
Preferred AA Shares^(4),(8)		15% PIK					15.00	%	12/10/2024		326,789		326,790		270,734		0.19	%
													1,481,712		270,734		0.19	%
Metal Powder Products, LLC, Common Shares^(4),(8)	Industrial Manufacturing										500,000		500,000		665,961		0.47	%
My Alarm Center, LLC, Common Shares^(4),(8)	Security										129,582		256,793		—		—
Junior Preferred Shares^(4),(8)											2,420		2,366,548		—		—

See notes to unaudited consolidated financial statements

Alcentra Capital Corporation and Subsidiary

Consolidated Schedule of Investments (continued)

As of June 30, 2019

(Unaudited)

Company(+) ***	Industry	Spread Above Index	Base Rate Floor	Interest Rate			Maturity Date	No. Shares/ Principal Amount		Cost⁽¹⁾		Fair Value			% of Net Assets
Senior Preferred Shares^(4),(8)		8% PIK			8.00	%	7/14/2022		2,998	$	2,862,059	$	1,023,603			0.72	%
											5,485,400		1,023,603			0.72	%
Palmetto Moon LLC, Common Shares^(4),(8)	Retail								61		434,145		81,200			0.06	%
Total Equity/Other											9,061,617		2,041,498			1.44	%
Total Investments in Non-Controlled, Non-Affiliated Portfolio Companies											213,022,113		204,633,762			144.17	%
Investments in Non-Controlled, Affiliated Portfolio Companies — 10.27%^*

Senior Subordinated — 0.86%

Battery Solutions, Inc. ⁽⁴⁾	Environmental/Recycling Services	12% Cash, 2% PIK			14.00	%	11/6/2021		1,225,019	$	1,225,019	$	1,225,020			0.86	%
Southern Technical Institute, Inc. ^(4),(8)	Education	6% PIK			6.00	%	12/31/2021		3,528,988		3,528,988		—			—
Total Senior Subordinated											4,754,007		1,225,020			0.86	%
Equity/Other — 9.41%

Battery Solutions, Inc., Class A Units^(4),(8),(9)	Environmental/Recycling Services								5,000,000	$	1,058,000	$	—			—
Class E Units⁽⁴⁾		8% PIK			8.00	%	11/6/2021		4,670,546		4,670,546		3,873,517			2.73	%
Class F Units^(4),(8)									3,333,333		—		—			—
											5,728,546		3,873,517			2.73	%
Conisus, LLC, Common Shares^(4),(8)	Media: Advertising, Printing & Publishing								4,914,556		—		—			—
Preferred Equity⁽⁴⁾		12% PIK			12.00	%			12,677,834		12,677,834		8,679,689			6.12	%
											12,677,834		8,679,689			6.12	%
Southern Technical Institute, Inc., Class A Units^(4),(8)	Education								3,164,063		2,167,000		—			—
Class A1 Units^(4),(8),(10)									6,000,000		—		—			—
											2,167,000		—			—
Xpress Global Systems, LLC, Class B Units ^(4),(8)	Transportation Logistics								12,544		1,254,000		795,212			0.56	%
Total Equity/Other											21,827,380		13,348,418			9.41	%
Total Investments in Non-Controlled, Affiliated Portfolio Companies											26,581,387		14,573,438			10.27	%
Total Investments											239,603,500		219,207,200			154.44	%
Liabilities In Excess Of Other Assets													(77,269,205	)		(54.44	)%
Net Assets												$	141,937,995			100.00	%

See notes to unaudited consolidated financial statements

Alcentra Capital Corporation and Subsidiary

Consolidated Schedule of Investments (continued)

As of June 30, 2019

(Unaudited)

⁽⁺⁾

All investments are qualifying assets under Section 55(a) of the 1940 Act, with the exception of the Company’s investments in Goldentree Loan Management US CLO 2 Ltd., Clanwilliam Group Ltd., and CGGR Operations Holdings Corporation. As of June 30, 2019, non-qualifying assets represented 10.5% of the Company’s total assets, at fair value.

Denotes investments in connection with which the Company is deemed to be an “Affiliated Person” under the 1940 Act because it owns 5% or more of the portfolio company’s outstanding voting securities or it has the power to exercise control over the management or policies of such portfolio company (including through a management agreement). Transactions as of and during the six months ended June 30, 2019 in which the issuer was an Affiliated Person (but not a portfolio company that the Company is deemed to Control) are as follows:

Name of Issuers	Fair Value at December 31, 2018		Gross Additions/ (Gross Reductions)		Transfers In/Out		Change in Unrealized Appreciation (Depreciation)			Realized Gain (Loss)		Fair Value at June 30, 2019		Interest/ Dividend/ Other Income
Battery Solutions, Inc.	$	5,699,791	$	195,775	$	-	$	(797,029	)	$	-	$	5,098,537	$	267,844
Conisus, LLC		6,554,225		-		-		2,125,464			-		8,679,689		-
Southern Technical Institute, Inc.		-		-		-		-			-		-		-
Xpress Global Systems, LLC		726,000		-		-		69,212			-		795,212		-
	$	12,980,016	$	195,775	$	-	$	1,397,647		$	-	$	14,573,438	$	267,844

^**

Denotes investments in connection with which the Company is deemed, under the 1940 Act, to be both an “Affiliated Person” and “Control” this portfolio company because it owns more than 25% of the portfolio company’s outstanding voting securities or it has the power to exercise control over the management or policies of such portfolio company (including through a management agreement). Transactions as of and during the six months ended June 30, 2019 in which the issuer was both an Affiliated Person of, and deemed to be Controlled by, the Company are as follows:

Name of Issuers	Fair Value at December 31, 2018		Gross Additions/ (Gross Reductions)			Transfers In/Out		Change in Unrealized Appreciation (Depreciation)			Realized Gain (Loss)		Fair Value at June 30, 2019		Interest/ Dividend/ Other Income
FST Technical Services, LLC⁽¹²⁾	$	16,406,021	$	(16,406,021	)	$	-	$	(1,193,459	)	$	1,193,459	$	-	$	341,633
	$	16,406,021	$	(16,406,021	)	$	-	$	(1,193,459	)	$	1,193,459	$	-	$	341,633

^***

Pledged as collateral under the Credit Facility with ING Capital LLC.

⁽¹⁾

The cost of debt securities is adjusted for accretion of discount/amortization of premium and interest paid-in-kind on such securities.

⁽²⁾

The principal balance outstanding for all floating rate loans is indexed to LIBOR, Euribor or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over LIBOR based on each respective credit agreement.

⁽³⁾

Security is classified as Level 2 in the Company’s fair value hierarchy (see Note 3).

⁽⁴⁾

Security is classified as Level 3 in the Company’s fair value hierarchy (see Note 3).

⁽⁵⁾

The investment has an unfunded commitment as of June 30, 2019 which is excluded from the presentation (see Note 12).

⁽⁶⁾

The investment was formerly known as LRI Holding, Inc. and Integrated Efficiency Solutions, Inc. On March 16, 2018, the name was changed to Envocore Holding, LLC.

⁽⁷⁾

The investment was formerly known as Cirrus Medical Staffing, Inc. On May 25, 2018, the name was changed to Epic Healthcare Staffing Intermediate Holdco, LLC.

⁽⁸⁾

Non-income producing security.

⁽⁹⁾

The Company has represented its ownership in Class A units in 919 BSI SPV, LLC (70.7% of that entity), which in turn owns 70,700 Class A Shares of Battery Solutions, LLC (representing 18.16% of ownership of Battery Solutions, LLC).

⁽¹⁰⁾

Class A1 units of 1,764,720 are subject to a deferred purchase agreement equal to 95% of future proceeds less $1.00.

⁽¹¹⁾

CGGR Holdings’ Tranche B Loan was reclassified to a second lien investment as a result of a sale of a portion of the Tranche A Loan to an unaffiliated third party.

⁽¹²⁾

FST Technical Services, LLC was sold on February 8, 2019.

Abbreviation Legend

LIBOR -	London Inter-bank Offered Rate
PIK -	Payment-In-Kind

See notes to unaudited consolidated financial statements

Alcentra Capital Corporation and Subsidiary

Consolidated Schedule of Investments

As of December 31, 2018

Company^(+)***	Industry	Spread Above Index	Base Rate Floor			Interest Rate			Maturity Date	No. Shares/ Principal Amount		Cost⁽¹⁾		Fair Value		% of Net Assets
Investments in Non-Controlled, Non-Affiliated Portfolio Companies — 140.89%
Senior Secured – First Lien — 106.14%
Black Diamond Oilfield Rentals, LLC^(2),(3),(15)	Oil & Gas Services	LIBOR + 6.50%		1.00	%		8.90	%	12/17/2020		11,385,109	$	11,385,109	$	11,382,254		7.81	%
Cambium Learning Group, Inc.^(3),(10)	Technology & Telecom	LIBOR + 4.50%					7.31	%	12/18/2025		4,000,000		3,800,000		3,800,000		2.61	%
CGGR Operations Holdings Corporation^(2),(3),(8)	Business Services	LIBOR + 11.5%		1.00	%		13.90	%	9/30/2023		13,431,579		13,324,053		13,431,579		9.21	%
		LIBOR + 7.0%		1.00	%		9.40	%	9/30/2022		9,468,421		9,397,345		9,468,421		6.49	%
													22,721,398		22,900,000		15.70	%
Champion ONE^(2),(3)	Technology & Telecom	LIBOR + 10.5%		1.00	%		12.90	%	3/17/2022		5,884,230		5,842,683		5,884,230		4.04	%
Clanwilliam Group Ltd.^(2),(3),(8)	Technology & Telecom	Euribor + 7.00%					7.00	%	11/8/2025	€	5,724,000		6,344,310		6,347,088		4.35	%
Envocore Holding, LLC^(2),(3),(7)	Industrial Services	LIBOR + 9.25%		1.00	%		11.65	%	6/30/2022		18,500,000		18,453,344		18,500,000		12.69	%
Epic Healthcare Staffing Intermediate Holdco, LLC^{(2),(3),(8),(9)}	Business Services	LIBOR + 8.25%		1.00	%		10.65	%	10/19/2022		13,430,114		13,392,406		13,430,114		9.21	%
Healthcare Associates of Texas, LLC^(2),(3),(8)	Healthcare Services	LIBOR + 8.0%		1.00	%		10.40	%	11/8/2022		20,578,816		20,578,816		20,578,816		14.11	%
Impact Group, LLC^(2),(3)	Consumer Services	LIBOR + 6.50%		1.00	%		9.21	%	6/27/2023		19,965,214		19,965,214		19,965,214		13.69	%
Lugano Diamonds & Jewelry, Inc.^(2),(3)	Retail	LIBOR + 10.00%		0.75	%		12.40	%	10/24/2021		6,750,000		6,229,503		6,365,358		4.37	%
Manna Pro Products, LLC^(2),(3),(8)	Consumer Services	LIBOR + 6.0%		1.00	%		8.31	%	12/8/2023		1,322,485		1,316,153		1,322,485		0.91	%
Palmetto Moon LLC⁽²⁾	Retail	11.5% Cash, 1.0% PIK					12.50	%	10/31/2021		4,737,622		4,720,936		4,648,350		3.19	%
Pinstripe Holdings, LLC^(2),(3)	Business Services	LIBOR + 6.00%					8.81	%	1/17/2025		10,000,000		9,800,000		9,800,000		6.72	%
Superior Controls, Inc.^(2),(3),(8)	Wholesale/ Distribution	LIBOR + 7.25%		1.00	%		9.65	%	3/22/2021		9,825,000		9,789,394		9,825,000		6.74	%
Total Senior Secured – First Lien													154,339,266		154,748,909		106.14	%
Senior Secured – Second Lien — 29.18%
BayMark Health Services, Inc.^(2),(3)	Healthcare Services	LIBOR + 8.25%		1.00	%		10.60	%	3/1/2025		7,000,000		6,938,172		7,000,000		4.80	%
Medsurant Holdings, LLC⁽²⁾	High Tech Industries	13.00% Cash					13.00	%	6/30/2020		8,729,396		8,701,223		8,729,396		5.99	%
Pharmalogic Holdings Corp.^(2),(3),(8)	Healthcare Services	LIBOR + 8.0%					10.34	%	12/11/2023		11,340,000		11,267,485		11,340,000		7.77	%
Sandvine Corporation^(2),(3)	Telecommunications	LIBOR + 8.00%					10.35	%	11/2/2026		4,500,000		4,410,000		4,410,000		3.02	%
VVC Holding Corp.^(2),(3),(5)	Healthcare Services	LIBOR + 8.13%		1.00	%		10.56	%	7/9/2026		6,000,000		5,943,433		6,120,000		4.20	%
WeddingWire, Inc.^(2),(3)	Consumer Services	LIBOR + 8.25%					11.06	%	12/21/2026		5,000,000		4,950,000		4,950,000		3.40	%
Total Senior Secured – Second Lien													42,210,313		42,549,396		29.18	%
CLO/Structured Credit — 1.20%
Goldentree Loan Management US CLO 2 Ltd.^(3),(10)	USD CLO	LIBOR + 4.70%					7.06	%	11/28/2030		2,000,000	$	1,948,058	$	1,739,600		1.20	%
Total CLO/Structured Credit													1,948,058		1,739,600		1.20	%

See notes to consolidated financial statements

Alcentra Capital Corporation and Subsidiary

Consolidated Schedule of Investments (continued)

As of December 31, 2018

Company^(+)***	Industry	Spread Above Index	Base Rate Floor	Interest Rate			Maturity Date		No. Shares/ Principal Amount		Cost⁽¹⁾		Fair Value		% of Net Assets
Equity/Other — 4.37%
Champion ONE, Common Shares^(2),(4)	Technology & Telecom									11,250	$	1,125,000	$	908,410		0.62	%
Envocore Holding, LLC, Preferred Shares^{(2),(4),(6),(7)}	Industrial Services									1,139,725		1,160,360		788,000		0.54	%
IGT, Preferred Shares^(2),(4)	Industrial Services	11% PIK			11.00	%		12/10/2024		1,110,922		1,110,922		—		—
Common Shares^(2),(4)										44,000		44,000		—		—
Preferred AA Shares^(2),(4)		15% PIK			15.00	%		12/10/2024		326,789		326,789		271,789		0.19	%
												1,481,711		271,789		0.19	%
Lugano Diamonds & Jewelry, Inc., Warrants^(2),(4)	Retail									666,615		666,615		1,000,000		0.69	%
Metal Powder Products, LLC, Common Shares^(2),(4)	Industrial Manufacturing									500,000		500,000		666,047		0.46	%
My Alarm Center, LLC, Common Shares^(2),(4)	Security									129,582		256,793		—		—
Junior Preferred Shares^(2),(4)										2,420		2,366,549		—		—
Senior Preferred Shares^(2),(4)		8% PIK			8.00	%		7/14/2022		2,998		2,862,059		1,023,999		0.70	%
												5,485,401		1,023,999		0.70	%
Palmetto Moon LLC, Common Shares^(2),(4)	Retail									61		434,145		106,000		0.07	%
Superior Controls, Inc., Preferred Shares^(2),(4)	Wholesale/ Distribution									400,000		400,000		789,192		0.54	%
Tunnel Hill, Class B Common Units^{(2),(4),(11),(14)}	Waste Services									98,418		2,529,303		820,437		0.56	%
Total Equity/Other												13,782,535		6,373,874		4.37	%
Total Investments in Non-Controlled, Non-Affiliated Portfolio Companies												212,280,172		205,411,779		140.89	%
Investments in Non-Controlled, Affiliated Portfolio Companies — 8.90%*
Senior Subordinated — 0.83%
Battery Solutions, Inc.⁽²⁾	Environmental/ Recycling Services	12% Cash, 2% PIK			14.00	%		11/6/2021		1,212,773	$	1,212,773	$	1,212,774		0.83	%
Southern Technical Institute, Inc.^(2),(4)	Education	6% PIK			6.00	%		12/31/2021		3,528,988		3,528,988		—		—
Total Senior Subordinated												4,741,761		1,212,774		0.83	%
Equity/Other — 8.07%
Battery Solutions, Inc., Class A Units^(2),(4),(12)	Environmental/ Recycling Services									5,000,000	$	1,058,000	$	—		—
Class E Units⁽²⁾		8% PIK			8.00	%		11/6/2021		4,487,017		4,487,017		4,487,017		3.08	%
Class F Units^(2),(4)										3,333,333		—		—		—
												5,545,017		4,487,017		3.08	%
Conisus, LLC, Common Shares^(2),(4)	Media: Advertising, Printing & Publishing									4,914,556		—		—		—
Preferred Equity⁽²⁾		12% PIK			12.00	%				12,677,834		12,677,834		6,554,225		4.49	%
												12,677,834		6,554,225		4.49	%
Southern Technical Institute, Inc., Class A Units^(2),(4)	Education									3,164,063		2,167,000		—		—
Class A1 Units^(2),(4),(13)										6,000,000		—		—		—
												2,167,000		—		—
Xpress Global Systems, LLC, Class B Units^(2),(4)	Transportation Logistics									12,544		1,254,000		726,000		0.50	%
Total Equity/Other												21,643,851		11,767,242		8.07	%
Total Investments in Non-Controlled, Affiliated Portfolio Companies												26,385,612		12,980,016		8.90	%

See notes to consolidated financial statements

Alcentra Capital Corporation and Subsidiary

Consolidated Schedule of Investments (continued)

As of December 31, 2018

Company^(+)***	Industry	Spread Above Index	Base Rate Floor	Interest Rate			Maturity Date	No. Shares/ Principal Amount		Cost⁽¹⁾		Fair Value			% of Net Assets
Investments in Controlled, Affiliated Portfolio Companies — 11.25%**
Senior Secured – First Lien — 9.19%
FST Technical Services, LLC⁽²⁾	Technology & Telecom	14% Cash			14.00	%	6/30/2019		13,406,020	$	13,406,020	$	13,406,020			9.19	%
Total Senior Secured – First Lien											13,406,020		13,406,020			9.19	%
Equity/Other — 2.06%
FST Technical Services, LLC, Class B Units^(2),(4)	Technology & Telecom	9% PIK			9.00	%			1,750,000	$	1,806,542	$	3,000,001			2.06	%
Total Equity/Other											1,806,542		3,000,001			2.06	%
Total Investments in Controlled, Affiliated Portfolio Companies											15,212,562		16,406,021			11.25	%
Total Investments											253,878,346		234,797,816			161.04	%
Liabilities In Excess Of Other Assets													(88,802,284	)		(61.04	)%
Net Assets												$	145,802,532			100.00	%

(+)

All investments are qualifying assets under Section 55(a) of the 1940 Act, with the exception of the Company’s investments in Goldentree Loan Management US CLO 2 Ltd., Clanwilliam Group Ltd., and CGGR Operations Holdings Corporation. As of December 31, 2018, non-qualifying assets represented 13.2% of the Company’s total assets, at fair value.

Denotes investments in connection with which the Company is deemed to be an “Affiliated Person” under the 1940 Act because it owns 5% or more of the portfolio company’s outstanding voting securities or it has the power to exercise control over the management or policies of such portfolio company (including through a management agreement). Transactions as of and during the year ended December 31, 2018 in which the issuer was an Affiliated Person (but not a portfolio company that the Company is deemed to Control) are as follows:

Name of Issuers	Fair Value at December 31, 2017		Gross Additions/ (Gross Reductions)			Transfers In/Out		Change in Unrealized Appreciation (Depreciation)			Realized Gain (Loss)			Fair Value at December 31 2018		Interest/ Dividend/ Other Income
Battery Solutions, Inc.	$	7,820,167	$	(843,377	)	$	—	$	(1,276,999	)	$	—		$	5,699,791	$	550,223
Conisus, LLC		6,678,442		—			—		(124,217	)		—			6,554,225		—
Show Media, Inc.		1							7,900,820			(7,900,821	)		—
Southern Technical Institute, Inc.		1		—			—		10,167,528			(10,167,529	)		—		—
Xpress Global Systems, LLC		5,474,294		38,166			—		1,689,002			(6,475,462	)		726,000		162,603
	$	19,972,905	$	(805,211	)	$	—	$	18,356,134		$	(24,543,812	)	$	12,980,016	$	712,826

Denotes investments in connection with which the Company is deemed, under the 1940 Act, to be both an “Affiliated Person” and “Control” this portfolio company because it owns more than 25% of the portfolio company’s outstanding voting securities or it has the power to exercise control over the management or policies of such portfolio company (including through a management agreement). Transactions as of and during the year ended December 31, 2018 in which the issuer was both an Affiliated Person of, and deemed to be Controlled by, the Company are as follows:

Name of Issuers	Fair value at December 31, 2017		Gross Additions/ (Gross Reductions)			Transfers In/Out		Change in Unrealized Appreciation (Depreciation)		Realized Gain (Loss)		Fair Value at December 31 2018		Interest/ Dividend/ Other Income
FST Technical Services, LLC	$	15,256,237	$	(593,739	)	$	—	$	1,743,523	$	—	$	16,406,021	$	1,940,389
	$	15,256,237	$	(593,739	)	$	—	$	1,743,523	$	—	$	16,406,021	$	1,940,389

***

Pledged as collateral under the Credit Facility with ING Capital LLC.

(1)

The cost of debt securities is adjusted for accretion of discount/amortization of premium and interest paid-in-kind on such securities.

(2)

Security is classified as Level 3 in the Company’s fair value hierarchy (see Note 3).

See notes to consolidated financial statements

Alcentra Capital Corporation and Subsidiary

Consolidated Schedule of Investments (continued)

As of December 31, 2018

(3)

The principal balance outstanding for all floating rate loans is indexed to LIBOR or an alternate base rate (e.g., prime rate or Euribor), which typically resets semi-annually, quarterly, or monthly at the borrower’s option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over LIBOR based on each respective credit agreement.

(4)

Non-income producing security.

(5)

The investment is also known as Value-Based Care Solutions Group, or VBC Technologies, or VVC Holding Corp.

(6)

The investment represents three classes of preferred equity.

(7)

The investment was formerly known as LRI Holding, Inc. and Integrated Efficiency Solutions, Inc. On March 16, 2018, the name was changed to Envocore Holding, LLC.

(8)

The investment has an unfunded commitment as of December 31, 2018 which is excluded from the presentation (see Note 12).

(9)

The investment was formerly known as Cirrus Medical Staffing, Inc. On May 25, 2018, the name was changed to Epic Healthcare Staffing Intermediate Holdco, LLC.

(10)

Security is classified as Level 2 in the Company’s fair value hierarchy (see Note 3).

(11)

The investment was formerly known as City Carting Holding Company, Inc. On June 3, 2016, City Carting combined with Tunnel Hill Partners, L.P.

(12)

(13)

Class A1 units of 1,764,720 are subject to a deferred purchase agreement equal to 95% of future proceeds less $1.00.

(14)

There is a possible escrow receivable up to a maximum of $2.4 million, which is excluded from the presentation.

(15)

Includes $2,855 of residual cost from previous tranche of debt, which will roll off in the first quarter of 2019.

Abbreviation Legend

PIK — Payment-In-Kind

See notes to consolidated financial statements

ALCENTRA CAPITAL CORPORATION AND SUBSIDIARY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2019

(Unaudited)

Organization and Purpose

Alcentra Capital Corporation (the “Company” or “Alcentra”) was formed as a Maryland corporation on June 6, 2013 as an externally managed, non-diversified closed-end management investment company that has elected to be regulated as a business development company under the Investment Company Act of 1940, as amended (the “1940 Act”). The Company is an investment company following the accounting and reporting guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 946, Financial Services – Investment Companies. Alcentra is managed by Alcentra NY, LLC (the “Adviser” or “Alcentra NY”), a registered investment adviser under the Investment Advisers Act of 1940, as amended (the “Advisers Act”). In addition, for U.S. federal income tax purposes, Alcentra has elected to be treated as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”). Alcentra NY, together with certain of its affiliated companies (the "Alcentra Group"), is an indirect, majority owned subsidiary of The Bank of New York Mellon Corporation.

The Company was formed for the purpose of acquiring certain assets held by BNY Mellon-Alcentra Mezzanine III, L.P. (the “Partnership”). The Partnership is a Delaware limited partnership, which commenced operations on May 14, 2010 (the “Commencement Date”). BNY Mellon-Alcentra Mezzanine III (GP), L.P. (the “General Partner”), a Delaware limited liability company, is the General Partner of the Partnership. BNY Mellon-Alcentra Mezzanine Partners (the “Manager”), a division of Alcentra NY and an affiliate of the General Partner, manages the investment activities of the Partnership.

On May 8, 2014 (commencement of operations), the Company acquired all of the assets of the Partnership other than its investment in the shares of common stock and warrants to purchase common stock of GTT Communications (the “Fund III Acquired Assets”) for $64.4 million in cash and $91.5 million in shares of Alcentra’s common stock. Concurrent with Alcentra’s acquisition of the Fund III Acquired Assets from the Partnership, Alcentra also purchased for $29 million in cash certain debt investments (the “Warehouse Portfolio”) from Alcentra Group. The Warehouse Portfolio debt investments were originated by the investment professionals of the Adviser and purchased by Alcentra Group using funds under a warehouse credit facility provided by The Bank of New York Mellon Corporation in anticipation of the initial public offering of Alcentra’s shares of common stock. Except for the $1,500 seed capital provided by Alcentra NY in exchange for 100 shares of Alcentra's common stock, the Company had no assets or operations prior to the acquisition of the investment portfolios of the Partnership and as a result, the Partnership is considered a predecessor entity of the Company.

On May 14, 2014, Alcentra completed its initial public offering (the “IPO”), at a price of $15.00 per share. Through the IPO the Company sold 6,666,666 shares for gross proceeds of approximately $100 million. Alcentra used $94.2 million of the proceeds from the IPO to fund the purchase of the warehouse portfolio, and the cash portion of the consideration paid to Fund III. On June 6, 2014, Alcentra sold 750,000 shares through the underwriters’ exercise of the overallotment option for gross proceeds of $11,250,000.

On April 8, 2014, the Company formed Alcentra BDC Equity Holdings, LLC, a wholly-owned subsidiary for tax purposes (the “Taxable Subsidiary”). The Taxable Subsidiary allows us to hold equity securities of portfolio companies organized as pass-through entities while continuing to satisfy the requirements of a RIC under the Code. The financial statements of this entity are consolidated into the financial statements of Alcentra. All intercompany balances and transactions have been eliminated.

On May 22, 2017, Alcentra Capital Corporation completed an underwritten primary offering of 808,161 shares of its common stock at a public offering price of $13.68 per share for proceeds of approximately $10,853,602, after paying the sales load and offering expenses.

The Company’s investment objective is to generate both current income and, to a lesser extent, capital appreciation primarily by making direct investments in middle-market companies, which the Company defines as companies having annual earnings, before interest, taxes, depreciation and amortization, or EBITDA of between $15 million and $75 million, although the Company may make investments in larger or smaller companies and other types of investments. These investments are in the form of first lien, second lien, unitranche and, to a lesser extent given the current credit environment, mezzanine debt. The Company expects to source investments primarily through the network of relationships that the principals of our investment adviser have developed with financial sponsor firms, financial institutions, middle-market companies, management teams and other professional intermediaries.

Upon commencement of operations, the Company also entered into an administration and custodian agreement (the “Administration Agreement”) with State Street Bank and Trust Company (the “Administrator”) to provide the Company with financial reporting, post-trade compliance and treasury services.

ALCENTRA CAPITAL CORPORATION AND SUBSIDIARY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)

June 30, 2019

(Unaudited)

Summary of Significant Accounting Policies

Basis of Presentation – The accompanying financial statements of the Company have been prepared on the accrual basis of accounting in accordance with U.S. generally accepted accounting principles (“GAAP”) and pursuant to the requirements for reporting on Form 10-Q and Articles 10 and 12 of Regulation S-X. Accordingly, certain financial information that is normally included in annual financial statements, including certain financial statement notes, prepared in accordance with GAAP, is not required for interim reporting purposes and have been omitted. In the opinion of management, the unaudited financial results included herein contain all adjustments considered necessary for the fair presentation of financial statements for the interim periods included herein. The current period’s results of operations will not necessarily be indicative of results that ultimately may be achieved for the fiscal year ending December 31, 2019.

The accounting records of the Company are maintained in United States dollars.

Use of Estimates – The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates and such differences could be material. The most significant estimates relate to the valuation of the Company’s portfolio investments.

Consolidation – In accordance with ASC Topic 810 - Consolidation, the Company generally will not consolidate its interest in any operating company other than in investment company subsidiaries, certain financing subsidiaries, and controlled operating companies substantially all of whose business consists of providing services to the Company.

Portfolio Investment Classification – The Company classifies its investments in accordance with the requirements of the 1940 Act. Under the 1940 Act, “Control Investments” are defined as investments in which the Company owns more than 25% of the voting securities or has rights to maintain greater than 50% of the board representation. Under the 1940 Act, “Affiliate Investments” are defined as investments in which the Company owns between 5% and 25% of the voting securities and does not have rights to maintain greater than 50% of the board representation. “Non-controlled, non-affiliate investments” are defined as investments that are neither Control Investments or Affiliate Investments.

Cash – At June 30, 2019, cash balances totaling $7.6 million exceeded FDIC insurance protection levels, subjecting the Company to risk related to the uninsured balance. All of the Company’s cash deposits are held by the Administrator and management believes that the risk of loss associated with any uninsured balance is remote.

Deferred Financing Costs – Deferred financing costs consist of fees and expenses paid in connection with the Credit Facility (as defined in Note 10) and are capitalized at the time of payment. These costs are amortized using the straight line method, which approximate the effective interest method over the term of the Credit Facility.

Deferred Note Offering Costs – Deferred note offering costs consist of fees and expenses paid in connection with the Notes (as defined in Note 9) and are capitalized at the time these fees and expenses are incurred before the issuance commenced. These costs are amortized using the straight line method, which approximate the effective interest method over the term of the Notes.

Valuation of Portfolio Investments – Portfolio investments are carried at fair value as determined by the Board of Directors (the ‘‘Board’’) of Alcentra.

The methodologies used in determining these valuations include:

(1) Preferred shares/membership units and common shares/membership units

In determining estimated fair value for common shares/membership units and preferred shares, the Company makes assessments of the methodologies and value measurements which market participants would use in pricing comparable investments, based on market data obtained from independent sources as well as from the Company’s own assumptions and taking into account all material events and circumstances which would affect the estimated fair value of such investments. Several types of factors, circumstances and events could affect the estimated fair value of the investments. These include but are not limited to the following:

ALCENTRA CAPITAL CORPORATION AND SUBSIDIARY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)

June 30, 2019

(Unaudited)

(i) Any material changes in the (a) competitive position of the portfolio investment, (b) legal and regulatory environment within which the portfolio investment operates, (c) management or key managers of the portfolio investment, (d) terms and/or cost of financing available to the portfolio investment, and (e) financial position or operating results of the investment;

(ii) pending disposition by the Company of the major portfolio investment; and

(iii) sales prices of recent public or private transactions in identical or comparable investments.

One or a combination of the following valuation techniques are used to fair value these investments: Market Approach and Income Approach. The Market Approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities. The Income Approach uses valuation techniques to convert future amounts to a present amount (i.e., discounting estimated future cash flows to a net present value amount).

(2) Debt

The fair value of performing debt investments is typically derived utilizing a market yield analysis. In a market yield analysis, a price is ascribed to each debt investment based upon an assessment of current and expected market yields for similar debt investments and risk profiles. Additional consideration is given to current contractual interest rates, relative maturities and other key terms and risks associated with a debt investment.

The Company considers many factors in evaluating the most suitable point within the range of fair values, including, but not limited to, the following:

the portfolio company’s underlying operating performance and any related trends;

the improvement or decline in the underlying credit quality measured on the basis of a loan-to-enterprise value ratio and total outstanding debt to EBITDA ratio; and

changes or issues related to the portfolio company’s customer/supplier concentration, regulatory developments and other portfolio company specific considerations.

(3) Warrants

Where warrants are considered to be in the money, their incremental value is included within the valuation of the investments.

Valuation techniques are applied consistently from period to period, except when circumstances warrant a change to a different valuation technique that will provide a better estimate of fair value.

With respect to the Company’s valuation process, the Board undertakes a similar multi-step valuation process each quarter in connection with determining the fair value of the Company's investments for which no market quotation is readily available, as described below:

Alcentra’s quarterly valuation process begins with each portfolio company or investment being initially valued by the investment professionals of the Adviser responsible for the portfolio investment;

preliminary valuation conclusions will then be documented and discussed with the investment committee of the Adviser;

Independent valuation firms engaged by the valuation committee of the Board prepare preliminary valuations on a select portion of the Company's investment portfolio on a quarterly basis and submit the reports to the Board; and

the valuation committee of the Board then reviews these preliminary valuations and makes a recommendation to the Board with respect thereto; and

the Board then discusses valuations and approves the fair value of each such investment in good faith, based on the input of the Adviser, the independent valuation firms and the valuation committee.

The valuation committee of the Board has authorized the engagement of independent valuation firms to provide Alcentra with valuation assistance. Alcentra intends to have independent valuation firms provide it with valuation assistance on a portion of its portfolio on a quarterly basis and its entire portfolio will be reviewed at least annually by independent valuation firms; however, the Board does not have de minimis investments of less than 1% of the Company’s gross assets (up to an aggregate of 10% of the Company’s gross assets) independently reviewed. The Board is ultimately responsible for the valuation of portfolio investments at fair value as approved in good faith pursuant to Alcentra’s valuation policy and a consistently applied valuation process.

ALCENTRA CAPITAL CORPORATION AND SUBSIDIARY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)

June 30, 2019

(Unaudited)

Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of the Company's investments, as determined by the Board, may differ significantly from the values that would have been used had a readily available market value existed for such investments, and the differences could be material. In addition, changes in the market environment and other events that may occur over the life of the investments may cause the gains or losses ultimately realized on these investments to be different than the valuations previously assigned.

Offering Costs – Offering expenses are expensed on the Company’s Consolidated Statements of Operations. Offering expenses consist principally of underwriter’s fee, legal, accounting, printing fees and other related expenses associated with the filing of a registration statement.

Paid-In-Capital – The Company records the proceeds from the sale of its common stock on a net basis to (i) capital stock and (ii) paid in capital in excess of par value, excluding all commissions.

Earnings and Net Asset Value Per Share – Earnings per share is calculated based upon the weighted average number of shares of common stock outstanding during the reported period. Net Asset Value per share is calculated using the number of shares outstanding as of the end of the period.

Investments – Investment security transactions are accounted for on a trade date basis. Cost of portfolio investments represents the actual purchase price of the securities acquired including capitalized legal, brokerage and other fees as well as the value of interest and dividends received in-kind and the accretion of original issue discounts. Fees may be charged to the issuer by the Company in connection with the origination of a debt security financing. Such fees are reflected as a discount to the cost of the portfolio security and the discount is accreted into income over the life of the related debt security.

Original Issue Discount – When the Company receives warrants with a nominal or discounted exercise price upon origination of a debt or preferred stock investment, a portion of the cost basis is allocated to the warrants. When the investment is made concurrently with the sale of a substantial amount of equity, the value of the warrants is based on the sales price. The value of the warrants is recorded as original issue discount (“OID”) to the value of the debt or preferred stock investment and the OID is amortized over the life of the investment.

Interest and Dividend Income – Interest is recorded on the accrual basis to the extent that the Company expects to collect such amounts. The Company accrues paid in-kind interest (“PIK”) by recording income and an increase to the cost basis of the related investments. Dividend income is recorded on ex-dividend date. Dividends in-kind are recorded as an increase in cost basis of investments and as income.

Investments that are expected to pay regularly scheduled interest in cash are generally placed on non-accrual status when principal or interest cash payments are past due 30 days or more and/or when it is no longer probable that principal or interest cash payments will be collected. Such non-accrual investments are restored to accrual status if past due principal and interest are paid in cash, and in management’s judgment, are likely to continue timely payment of their remaining principal and interest obligations. Cash interest payments received on non-accrual designated investments may be recognized as income or applied to principal depending on management’s judgment. There was one non-accrual investment as of each of June 30, 2019 and December 31, 2018.

Other Income – The Company may also receive structuring or closing fees in connection with its investments. Such upfront fees are accreted into income over the life of the investment. These fees are non-recurring in nature.

Prepayment penalties received by the Company for debt instruments paid back to the Company prior to the maturity date are recorded as income upon receipt.

Income Taxes – The Company has elected to be treated for U.S. federal income tax purposes as a RIC under Subchapter M of the Code, and to operate in a manner to qualify for the tax treatment applicable to RIC’s. To obtain and maintain our qualification for taxation as a RIC, the Company must, among other things, meet certain source-of-income and asset diversification requirements. In addition, the Company must distribute to its stockholders, for each taxable year, at least 90% of ‘‘investment company taxable income,’’ which is generally net ordinary taxable income plus the excess of realized net short-term capital gains over realized net long-term capital losses, or the Annual Distribution Requirement. As a RIC, the Company generally will not pay corporate-level U.S. federal income taxes on any ordinary income or capital gains that are timely distributed to stockholders as dividends.

ALCENTRA CAPITAL CORPORATION AND SUBSIDIARY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)

June 30, 2019

(Unaudited)

The Taxable Subsidiary permits the Company to hold equity investments in portfolio companies which are “pass through” entities for tax purposes and continue to comply with the “source income” requirements contained in RIC tax provisions of the Code. The Taxable Subsidiary is not consolidated with the Company for income tax purposes and may generate income tax expense, benefit, and the related tax assets and liabilities, as a result of its ownership of certain portfolio investments. The income tax expense, or benefit, if any, and related tax assets and liabilities are reflected in the Company’s consolidated financial statements. The Taxable Subsidiary uses the asset and liability method of accounting for income taxes. This method requires the recognition of deferred tax liabilities and assets for the expected future tax consequences of temporary differences between financial accounting bases and tax bases of assets and liabilities. The tax benefits of tax loss carryforwards and other deferred taxes are recorded as an asset to the extent that management assesses the utilization of such assets to be more likely than not. Management routinely assesses the realizability of the deferred income tax assets, and a valuation allowance is recognized if it is determined that deferred income tax assets may not be fully utilized in future periods. Management considers future taxable earnings in making such assessments. Numerous judgments and assumptions are inherent in the determination of future taxable earnings, including such factors as future operating conditions. When the future utilization of some portion of the deferred tax asset is determined not to be more likely than not, a valuation allowance is provided to reduce the recorded deferred tax asset. When management can project that a portion of the deferred tax asset can be realized through application of a portion of tax loss carryforward, management will record that utilization as a deferred tax benefit and recognize a deferred tax asset in the same amount. There can be no assurance that facts and circumstances will not materially change and require the recording of any deferred tax asset valuation allowance in future periods. For the three and six months ended June 30, 2019, the Company recognized a provision for income tax on unrealized gain on investments of $0.9 million and $1.1 million, respectively, for the Taxable Subsidiary. For the three and six months ended June 30, 2018, the Company recognized a benefit for income taxes on unrealized loss on investments of $1.0 million and $1.0 million, respectively, for the Taxable Subsidiary. As of June 30, 2019 and December 31, 2018, the Company had a deferred tax asset in the amount of $4.3 million and $5.4 million, respectively, primarily relating to tax loss carryforwards. The decrease in the deferred tax asset resulted from a valuation allowance recorded during the quarter.

The deferred tax asset of $4.3 million (after a 21% tax rate) is comprised of the following: (1) $1.0 million of NOL’s; (2) $0.7 million of capital losses; (3) $3.4 million of partnership losses, offset by (4) $0.8 of a valuation allowance. GAAP provides guidance for how uncertain tax positions should be recognized, measured, presented and disclosed in the financial statements. GAAP requires the evaluation of tax positions taken or expected to be taken in the course of preparing the Company’s financial statements to determine whether the tax positions are “more-likely-than-not” of being sustained by the applicable tax authority. The Company has analyzed such tax positions and has concluded that no unrecognized tax benefits should be recorded for uncertain tax positions for tax years that may be open for the quarter ended June 30, 2019. This conclusion may be subject to review and adjustment at a later date based on factors, including but not limited to, ongoing analysis and changes to laws, regulations, and interpretations thereof.

Indemnification – In the normal course of business, the Company enters into contractual agreements that provide general indemnifications against losses, costs, claims and liabilities arising from the performance of individual obligations under such agreements. The Company has had no prior claims or payments pursuant to such agreements. The Company’s individual maximum exposure under these arrangements is unknown, as this would involve future claims that may be made against the Company that have not yet occurred. However, based on management’s experience, the Company expects the risk of loss to be remote.

Recently Issued Accounting Standards – In March 2017, the FASB issued ASU 2017-08, Premium Amortization on Purchased Callable Debt Securities, which amended FASB ASC 310-20. The amendments in ASU 2017-08 shortened the amortization period for certain callable debt securities held at a premium, generally requiring the premium to be amortized to the earliest call date. For public business entities, the amendments became effective for fiscal years beginning after December 15, 2018, as well as for interim periods within those fiscal years. The Company adopted ASU 2017-08 in connection with its quarterly report on Form 10-Q for the three months ended March 31, 2019. Such adoption did not have a material impact on the Company’s financial statements.

In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820), Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement. The amendments in this Update modify the disclosure requirements on fair value measurement in Topic 820, Fair Value Measurement, based on the concepts in the Concepts Statement, including the consideration of costs and benefits. ASU 2018-13 is effective for all entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. Early adoption is permitted. The Company has adopted ASU 2018-13 in its consolidated financial statements and disclosures with no material impact.

In August 2018, the U.S. Securities and Exchange Commission adopted final rules to eliminate redundant, duplicative, overlapping, outdated or superseded disclosure requirements in light of other disclosure requirements, GAAP or changes in the information environment. These rules amend certain provisions of Regulation S-X and Regulation S-K, certain rules promulgated under the Securities Act of 1933 and the Securities Exchange Act of 1934 and certain related forms. The Company has adopted these changes in its consolidated financial statements and disclosures with no material impact.

ALCENTRA CAPITAL CORPORATION AND SUBSIDIARY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)

June 30, 2019

(Unaudited)

In May 2014, the FASB issued ASC 606, Revenue From Contracts With Customers, originally effective for public business entities with annual reporting periods beginning after December 15, 2016. On August 12, 2015, the FASB issued an ASU, Revenue From Contracts With Customers (Topic 606): Deferral of the Effective Date, which deferred the effective date of ASC 606 for one year. ASC 606 provides accounting guidance related to revenue from contracts with customers. For public business entities, ASC 606 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2017. The Company has evaluated the impact of ASC 606 and determined that it will not have a material impact on its consolidated financial statements and disclosures.

Fair Value of Portfolio Investments

The Company accounts for its investments in accordance with FASB Accounting Standards Codification Topic 820 (“ASC Topic 820”), Fair Value Measurements and Disclosures, which defines fair value, establishes a framework for measuring fair value. ASC Topic 820 established a fair value hierarchy which prioritizes and ranks the level of market price observability used in measuring investments at fair value.

Market price observability is impacted by a number of factors, including the type of investment, the characteristics specific to the investment, and the state of the marketplace (including the existence and transparency of transactions between market participants). Investments with readily-available actively quoted prices or for which fair value can be measured from actively-quoted prices in an orderly market will generally have a higher degree of market price observability and a lesser degree of judgment used in measuring fair value.

Investments measured and reported at fair value are classified and disclosed in one of the following categories (from highest to lowest) based on inputs:

Level 1 – Quoted prices (unadjusted) are available in active markets for identical investments that the Company has the ability to access as of the reporting date. The type of investments which would generally be included in Level 1 includes listed equity securities and listed derivatives. As required by ASC Topic 820, the Company, to the extent that it holds such investments, does not adjust the quoted price for these investments, even in situations where the Company holds a large position and a sale could reasonably impact the quoted price.

Level 2 – Pricing inputs are observable for the investments, either directly or indirectly, as of the reporting date, but are not the same as those used in Level 1. Fair Value is based on quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly.

Level 3 – Pricing inputs are unobservable for the investment and include situations where there is little, if any, market activity for the investment. The inputs into the determination of fair value require significant judgment or estimation by the Company. The types of investments which would generally be included in this category include debt and equity securities issued by private entities.

In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the determination of which category within the fair value hierarchy is appropriate for any given investment is based on the lowest level of input that is significant to the fair value measurement. The Company's assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and considers factors specific to the investment.

The fair values of our investments disaggregated into the three levels of the fair value hierarchy based upon the lowest level of significant input used in the valuation as of June 30, 2019 are as follows:

	Level 1		Level 2		Level 3		Total
Senior Secured - First Lien	$	—	$	7,162,215	$	128,361,939	$	135,524,154
Senior Secured - Second Lien		—		—		65,239,620		65,239,620
Subordinated Debt		—		—		1,225,020		1,225,020
CLO/Structured Credit		—		1,828,490		—		1,828,490
Equity/Other		—		—		15,389,916		15,389,916
Total Investments	$	—	$	8,990,705	$	210,216,495	$	219,207,200

The fair values of our investments disaggregated into the three levels of the fair value hierarchy based upon the lowest level of significant input used in the valuation as of December 31, 2018 are as follows:

	Level 1		Level 2		Level 3		Total
Senior Secured – First Lien	$	-	$	3,800,000	$	164,354,929	$	168,154,929
Senior Secured – Second Lien		-		-		42,549,396		42,549,396
Subordinated Debt		-		-		1,212,774		1,212,774
CLO/Structured Credit		-		1,739,600		-		1,739,600
Equity/Other		-		-		21,141,117		21,141,117
Total investments	$	-	$	5,539,600	$	229,258,216	$	234,797,816

ALCENTRA CAPITAL CORPORATION AND SUBSIDIARY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)

June 30, 2019

(Unaudited)

The changes in investments classified as Level 3 are as follows for the six months ended June 30, 2019 and June 30, 2018.

As of June 30, 2019:

	Senior			Senior
	Secured -			Secured -			Senior		Equity/
	First Lien			Second Lien			Subordinated		Other			Total
Balance as of January 1, 2019	$	164,354,929		$	42,549,396		$	1,212,774	$	21,141,117		$	229,258,216
Amortized discounts/premiums		745,945			242,474			-		-			988,419
Paid in-kind interest		113,301			-			6,074		183,529			302,904
Net realized gain (loss)		68,711			-			-		1,013,030			1,081,741
Net change in unrealized appreciation (depreciation)		(1,920,653	)		43,697			-		592,730			(1,284,226	)
Purchases		33,819,312			17,200,000			6,172		400,000			51,425,484
Sales/Return of capital		(59,295,553	)		(8,120,000	)		-		(7,940,490	)		(75,356,043	)
Lien status change		(13,324,053	)		13,324,053			-		-			-
Transfers in		3,800,000			-			-		-			3,800,000
Transfers out		-			-			-		-			-
Balance as of June 30, 2019	$	128,361,939		$	65,239,620		$	1,225,020	$	15,389,916		$	210,216,495

Net change in unrealized appreciation (depreciation) from investments still held as of June 30, 2019	$	(1,522,345	)	$	128,749		$	-	$	583,310		$	(810,286	)

As of June 30, 2018:

	Senior			Senior
	Secured -			Secured -			Senior			Equity/
	First Lien			Second Lien			Subordinated			Other			Total
Balance as of January 1, 2018	$	177,340,027		$	14,203,691		$	66,884,849		$	29,125,978		$	287,554,545
Amortized discounts/premiums		165,255			24,736			155,059			-			345,050
Paid in-kind interest		81,763			-			207,222			169,276			458,261
Net realized gain (loss)		(24,418	)		(4,922,041	)		(10,098,674	)		(5,245,476	)		(20,290,609	)
Net change in unrealized appreciation (depreciation)		(163,436	)		7,750,383			5,280,892			565,315			13,433,154
Purchases		10,880,846			18,189,499			2,277,803			-			31,348,148
Sales/Return of capital		(37,984,277	)		(3,529,000	)		(41,252,701	)		-			(82,765,978	)
Transfers in		-			-			-			-			-
Transfers out		-			-			-			-			-
Balance as of June 30, 2018	$	150,295,760		$	31,717,268		$	23,454,450		$	24,615,093		$	230,082,571

Net change in unrealized appreciation (depreciation) from investments still held as of June 30, 2018	$	(60,534	)	$	(700,657	)	$	(5,373,294	)	$	(4,680,161	)	$	(10,814,646	)

ALCENTRA CAPITAL CORPORATION AND SUBSIDIARY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)

June 30, 2019

(Unaudited)

The following is a summary of the quantitative inputs and assumptions used for items categorized in Level 3 of the fair value hierarchy as of June 30, 2019 and December 31, 2018, respectively.

As of June 30, 2019:

	Fair Value at
Assets at Fair Value	June 30, 2019		Valuation Technique	Unobservable Input	Range of Inputs	Weighted Average

Senior Secured - First Lien	$	128,361,939	Yield to Maturity	Comparable Market Rate	6.8% - 17.1%		10.1	%

Senior Secured - Second Lien		65,239,620	Yield to Maturity	Comparable Market Rate	10.3% - 14.3%		10.5	%

Senior Subordinated		1,225,020	Yield to Maturity	Comparable Market Rate	14.0% - 14.2%		14.1	%

Preferred Ownership		13,847,543	Market Approach	Enterprise Value / LTM EBITDA Multiple / Transaction price	6.0x - 10.5x		8.2	x

Common Ownership/ Common Warrants		1,542,373	Market Approach	Enterprise Value / LTM EBITDA Multiple / Transaction price	4.5x - 10.5x		6.5	x

Total	$	210,216,495

As of December 31, 2018:

	Fair Value at
Assets at Fair Value	December 31, 2018		Valuation Technique	Unobservable Input	Range of Inputs	Weighted Average

Senior Secured - First Lien	$	164,354,929	Yield to Maturity	Comparable Market Rate	7.0% - 14.0%		10.7	%

Senior Secured - Second Lien		42,549,396	Yield to Maturity	Comparable Market Rate	10.3% - 13.0%		11.0	%

Senior Subordinated		1,212,774	Yield to Maturity	Comparable Market Rate	14.0%		14.0	%

Preferred Ownership		16,914,223	Market Approach	Enterprise Value / LTM EBITDA Multiple / Transaction price	5.5x - 12.0x		7.4	x

Common Ownership/ Common Warrants		4,226,894	Market Approach	Enterprise Value / LTM EBITDA Multiple / Transaction price	4.5x - 12.0x		8.1	x

Total	$	229,258,216

Share Transactions

On November 2, 2017, the Board approved a $2.5 million open market stock repurchase program. Pursuant to the program, the Company was authorized to repurchase up to $2.5 million in aggregate of our common stock in the open market. The timing, manner, price and amount of any share repurchases were determined by our management, in its discretion, based upon the evaluation of economic conditions, stock price, applicable legal and regulatory requirements and other factors. Repurchases under the program were authorized through November 2, 2018.

On November 16, 2017, the Board approved expansion of the open market stock repurchase program to $5.0 million and extension of the length of the program to January 31, 2019.

As of August 8, 2018, the Company repurchased an aggregate of $5.0 million shares of our common stock under the discretionary open-market share repurchase program and, as a result, the program terminated on such date in accordance with its terms. Subsequently, pursuant to the Board authorization on November 5, 2018, the Company adopted a trading plan on December 10, 2018 for the purpose of repurchasing shares of its common stock in the open market (the "Plan"). Under the Plan, the Company may repurchase up to the lesser of (1) 5.0% of the amount of shares of the Company's common stock outstanding as of the date of the Plan, December 10, 2018 and (2) $10.0 million in aggregate amount of the Company's common stock.

ALCENTRA CAPITAL CORPORATION AND SUBSIDIARY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)

June 30, 2019

(Unaudited)

The following tables set forth the number of shares of common stock repurchased by the Company under its share repurchase programs for the six months ended June 30, 2019 and June 30, 2018:

Six months ended June 30, 2019:

Month Ended	Shares Repurchased		Repurchase Price Per Share	Aggregate Consideration for Repurchased Shares
January 2019		207,220	$6.50 - $6.99	$	1,318,920
February 2019		22,509	$6.95 - $7.00		157,495
Total		229,729		$	1,476,415

Six months ended June 30, 2018:

Month Ended	Shares Repurchased		Repurchase Price Per Share	Aggregate Consideration for Repurchased Shares
January 2018		16,786	$8.01 - $8.22	$	136,949
March 2018		195,785	$6.05 - $7.24		1,373,656
April 2018		231,343	$6.12 - $7.20		1,599,304
May 2018		136,819	$6.18 - $6.85		901,837
June 2018		59,461	$6.30 - $6.80		397,913
Total		640,194		$	4,409,659

Distributions

The Company intends to make quarterly distributions of available net investment income determined on a tax basis to its stockholders. Distributions to stockholders are recorded on the record date. The amount, if any, to be distributed to stockholders is determined by the Board each quarter and is generally based upon the earnings estimated by management. Net realized capital gains, if any, will be distributed at least annually. If the Company does not distribute (or are not deemed to have distributed) at least (i) 98% of the Company's annual ordinary income in the calendar year earned (the “required distribution”), (ii) 98.2% of capital gain net income (adjusted for certain ordinary losses) for the one-year period ending October 31 of that calendar year, and (iii) any income or capital gains recognized, but not distributed, in preceding calendar years and on which the Company incurred no federal income tax, the Company will generally be required to pay an excise tax equal to 4% of the amount by which the required distribution exceeds the distributions from such taxable income for the year. To the extent that the Company determines that its estimated current year annual taxable income will be in excess of estimated current year dividend distributions from such taxable income, the Company accrues excise taxes, if any, on estimated excess taxable income. As of June 30, 2019 and December 31, 2018, the Company accrued $392,007 and $435,797, respectively, for any unpaid potential excise tax liability and have included these amounts within income tax asset or liability on the accompanying Consolidated Statements of Assets and Liabilities.

The following table reflects the dividends on the Company’s common stock declared by the Board and paid for the six months ended June 30, 2019:

Date Declared	Record Date	Payment Date	Amount Per Share
March 11, 2019	March 29, 2019	April 4, 2019	$	0.18
May 3, 2019	June 28, 2019	July 3, 2019	$	0.33

The following table reflects the dividends on the Company’s common stock declared by the Board and paid for the six months ended June 30, 2018:

Date Declared	Record Date	Payment Date	Amount Per Share
March 8, 2018	March 30, 2018	April 4, 2018	$	0.18
May 4, 2018	June 29, 2018	July 5, 2018	$	0.18

ALCENTRA CAPITAL CORPORATION AND SUBSIDIARY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)

June 30, 2019

(Unaudited)

The Company has adopted a dividend reinvestment plan (“DRIP”) that provides for the reinvestment of dividends on behalf of its stockholders, unless a stockholder has elected to receive dividends in cash. As a result, if the Company declares a cash dividend, the stockholders who have not “opted out” of the DRIP no later than the record date will have their cash dividend automatically reinvested into additional shares of the Company’s common stock. The Company has the option to satisfy the share requirements of the DRIP through the issuance of new shares of common stock or through open market purchases of common stock by the DRIP plan administrator. Newly issued shares are valued based upon the final closing price of the common stock on the NASDAQ Global Select Market on the dividend payment date. Shares purchased in the open market to satisfy the DRIP requirements will be valued upon the average price of the applicable shares purchased by the plan administrator, before any associated brokerage or other costs.

Related Party Transactions

Management Fee

Under the Investment Advisory Agreement, the Company has agreed to pay Alcentra NY an annual base management fee, which is calculated at an annual rate as follows: 1.50% of its gross assets (i.e., total assets held before deduction of any liabilities), including assets purchased with borrowed funds or other forms of leverage and excluding cash and cash equivalents (such as investments in U.S. Treasury Bills), if its gross assets are less than or equal to $625,000,000; 1.40% if its gross assets are greater than or equal to $625,000,001 but less than or equal to $750,000,000; and 1.25% if its gross assets are greater than or equal to $750,000,001. The various management fee percentages (i.e. 1.50%, 1.40% and 1.25%) would apply to the Company’s entire gross assets in the event its gross assets exceed the various gross asset thresholds. The base management fee is payable quarterly in arrears and is calculated based on the average value of the Company’s gross assets, excluding cash and cash equivalents, at the end of the two most recently completed calendar quarters.

On May 4, 2018, the Adviser agreed to a temporary voluntary 25 basis point reduction, from May 1, 2018 to April 30, 2019, across all of these base management fee breakpoints. On May 3, 2019, the Adviser agreed to a continuation of the temporary 25 basis point reduction across all of the base management fee breakpoints under the Investment Advisory Agreement, effective from May 1, 2019 to April 30, 2020.

The incentive fee consists of two parts. The first part, which is calculated and payable quarterly in arrears, equals 20% of the Company's ‘‘pre-incentive fee net investment income’’ for the immediately preceding quarter, subject to a hurdle rate of 2% per quarter, and is subject to a ‘‘catch-up’’ feature. The “catch-up” feature is intended to provide the Adviser with an incentive fee of 50% of the Company’s “pre-incentive fee net investment income” as if a preferred return did not apply when our net investment income exceeds 2.5% in any quarter.

The foregoing incentive fee is subject to a total return requirement, which provides that no incentive fee in respect of our pre-incentive fee net investment income is payable except to the extent 20.0% of the cumulative net increase in net assets resulting from operations over the then current and 11 preceding quarters exceeds the cumulative incentive fees accrued and/or paid for the 11 preceding quarters. In other words, any ordinary income incentive fee that is payable in a calendar quarter is limited to the lesser of (i) 20.0% of the amount by which our pre-incentive fee net investment income for such calendar quarter exceeds the 2.0% hurdle, subject to the “catch-up” provision, and (ii) (x) 20.0% of the cumulative net increase in net assets resulting from operations for the then current and 11 preceding calendar quarters minus (y) the cumulative incentive fees accrued and/or paid for the 11 preceding calendar quarters. For the foregoing purpose, the “cumulative net increase in net assets resulting from operations” is the amount, if positive, of the sum of pre-incentive fee net investment income, realized gains and losses and unrealized appreciation and depreciation for our then current and 11 preceding calendar quarters. In addition, the portion of such incentive fee that is attributable to deferred interest (such as PIK interest or OID) is paid to the Adviser, together with interest thereon from the date of deferral to the date of payment, only if and to the extent that the Company actually receives such interest in cash, and any accrual thereof will be reversed if and to the extent such interest is reversed in connection with any write-off or similar treatment of the investment giving rise to any deferred interest accrual. Any reversal of such accounts would reduce net income for the quarter by the net amount of the reversal (after taking into account the reversal of incentive fees payable) and would result in a reduction and possible elimination of the incentive fees for such quarter. There is no accumulation of amounts on the hurdle rate from quarter to quarter, and accordingly there is no clawback of amounts previously paid if subsequent quarters are below the quarterly hurdle, and there is no delay of payment if prior quarters are below the quarterly hurdle. The Adviser has agreed to permanently waive any interest accrued on the portion of the incentive fee attributable to deferred interest (such as PIK interest or OID).

The second part is calculated and payable in arrears as of the end of each calendar year (or, upon termination of the Investment Advisory Agreement, as of the termination date) and equals 20% of our aggregate cumulative realized capital gains from inception through the end of each calendar year, computed net of aggregate cumulative realized capital losses and aggregate cumulative unrealized capital depreciation through the end of such year, less the aggregate amount of any previously paid capital gain incentive fees. Pre-incentive fee net investment income means interest income, dividend income and any other income (including any other fees, such as commitment, origination, structuring, diligence, managerial assistance and consulting fees or other fees that the Company receives from portfolio companies) accrued during the calendar quarter, minus our operating expenses for the quarter (including the base management fee, expenses payable for administrative services under the Investment Advisory Agreement, and any interest expense and any distributions paid on any issued and outstanding preferred stock, but excluding the incentive fee and any offering expenses and other expenses not charged to operations but excluding certain reversals to the extent such reversals have the effect of reducing previously accrued incentive fees based on the deferral of non-cash interest). Pre-incentive fee net investment income excludes, in the case of investments with a deferred interest feature (such as original issue discount, debt instruments with PIK interest and zero coupon securities), accrued income until the Company has received such income in cash.

ALCENTRA CAPITAL CORPORATION AND SUBSIDIARY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)

June 30, 2019

(Unaudited)

For the three and six months ended June 30, 2019, the Company recorded expenses for base management fees of $841,566 and $1,707,184, respectively, of which $140,261 and $284,531, respectively, was waived by the Adviser pursuant to the voluntary waiver as part of the Investment Advisory Agreement and $701,305 was payable at June 30, 2019. For the three and six months ended June 30, 2018, the Company recorded expenses for base management fees of $1,036,122 and $2,270,985, respectively, of which $109,281 and $109,281, respectively, was waived by the Adviser and $926,841 was payable at June 30, 2018.

For the three and six months ended June 30, 2019, the Company reversed $204,867 and $691,991, respectively, in previously accrued income-based incentive fees. For the three and six months ended June 30, 2018, the Company incurred no incentive fees. As of June 30, 2019 and June 30, 2018, $198,805 and $1,294,985 in income-based incentive fees, respectively, was payable by the Company. For each of the three and six months ended June 30, 2019 and June 30, 2018, the Company incurred capital gains incentive fees of $0.

The Company’s officers are employees of the Adviser and the Company may pay the allocable portion of the compensation of the Company’s Chief Financial Officer and Chief Compliance Officer and their staffs pursuant to the Investment Advisory Agreement.

Directors' Fees

The Company’s independent directors each receive an annual fee of $40,000. They also receive $2,500 plus reimbursement of reasonable out-of-pocket expenses incurred in connection with attending in-person each Board meeting and $1,000 for each Board meeting they participate in telephonically. In addition, each independent director receives $1,000 plus reimbursement of reasonable out-of-pocket expenses incurred in connection with each audit committee, compensation committee, nominating and corporate governance committee, and valuation committee meeting attended in person or telephonically. The chair of the audit committee receives an annual fee of $10,000, and the respective chairs of the compensation committee, the nominating and corporate governance committee and the valuation committee each receives an annual fee of $5,000. The lead independent director also receives an annual fee of $15,000. The Board may establish ad hoc committees or working groups from time to time to assist the Board in fulfilling its oversight responsibilities, and the independent directors may receive fees and be reimbursed for reasonable out-of-pocket expenses incurred in connection therewith.

In connection with the Board’s review of strategic alternatives, the Board established a Committee of Independent Directors during 2018, which is comprised of each of the Board’s independent directors and met throughout 2018 on a periodic basis. Effective April 2018, each member of the Committee of Independent Directors received a monthly fee of $1,000, and the chair of the Committee of Independent Directors received an additional monthly retainer of $5,000 for his services as chair and the increased responsibilities associated therewith. Effective November 2018, each member of the Committee of Independent Directors received $1,000 plus reimbursement of reasonable out-of-pocket expenses incurred in connection with each meeting of the committee attended in person or telephonically. In addition, the chair of the Committee of Independent Directors receives a monthly retainer of $4,000 for his services as chair and the increased responsibilities associated therewith. Effective May 1, 2019, each member of the Committee of the Independent Directors receives a $10,000 monthly retainer in lieu of the $1,000 per meeting fee that was effective starting in November 2018. In addition, the chair of the Committee of Independent Directors receives an additional $5,000 monthly retainer in lieu of the previous $4,000 monthly retainer.

The Company has obtained directors’ and officers’ liability insurance on behalf of its directors and officers.

For the three and six months ended June 30, 2019, the Company recorded directors' fee expense of $215,000 and $374,676, respectively, of which $197,154 was payable at June 30, 2019. For the three and six months ended June 30, 2018, the Company recorded directors' fee expense of $116,826 and $213,028, respectively, of which $36,125 was payable at June 30, 2018.

Purchases and Sales (Investment Transactions)

Investment purchases, sales and principal payments/paydowns are summarized below for the six months ended June 30, 2019 and June 30, 2018.

	For the six months ended June 30,
	2019		2018
Investment purchases, at cost (including PIK interest and dividends)	$	59,038,873	$	44,507,064
Investment sales, proceeds (including principal payments/paydown proceeds)		75,393,530		79,266,967

ALCENTRA CAPITAL CORPORATION AND SUBSIDIARY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)

June 30, 2019

(Unaudited)

Alcentra Capital InterNotes®

On January 30, 2015, the Company entered into a Selling Agent Agreement with Incapital LLC, as purchasing agent for the Company's issuance of $40.0 million of Alcentra Capital InterNotes®. On January 25, 2016, the Company entered into an additional Selling Agent Agreement with Incapital LLC, as purchasing agent for the Company’s issuance of up to $15 million of Alcentra Capital InterNotes®.

These notes (the "Notes") are direct unsecured obligations and each series of notes has been issued by a separate trust (administered by U.S. Bank). The notes bear interest at fixed interest rates and offer a variety of maturities no less than twelve months from the original date of issuance.

During each of the six months ended June 30, 2019 and June 30, 2018, the Company did not issue any Alcentra Capital InterNotes®. For the three and six months ended June 30, 2019, the Company had average Notes outstanding of $55.0 million and $55.0 million (principal amount), respectively, with a weighted average interest rate of 6.40% and 6.44%, respectively. For the three and six months ended June 30, 2018, the Company borrowed an average of $55.0 million and $55.0 million, respectively, with a weighted average interest rate of 6.40% and 6.44%, respectively.

The following table summarizes the Alcentra Capital InterNotes® issued and outstanding as of June 30, 2019.

Tenor at	Principal		Interest	Weighted
Origination	Amount		Rate	Average
(in years)	(000’s omitted)		Range	Interest Rate			Maturity Date Range
5	$	53,582	6.25% - 6.50%		6.38	%	February 15, 2020 - June 15, 2021
7		1,418	6.50% - 6.75%		6.63	%	January 15, 2022 - April 15, 2022
	$	55,000

In connection with the issuance of the Alcentra Capital InterNotes®, the Company incurred $1.196 million of fees which are being amortized over the term of the notes and are included within deferred financing costs on the Consolidated Statements of Assets and Liabilities as of June 30, 2019. During the six months ended June 30, 2019 and June 30, 2018, the Company recorded $0.243 million and $0.246 million of amortization of deferred note offering costs on the Alcentra Capital InterNotes®.

10.

Credit Facility/Line of Credit

On May 8, 2014, the Company entered into a senior secured revolving credit agreement (as amended and restated from time to time, the “Credit Facility”) with ING Capital LLC (“ING”), as administrative agent, collateral agent and lender, and the lenders from time to time party thereto, to provide liquidity in support of its investment and operational activities. The Credit Facility had an initial commitment of $80 million with an accordion feature that allowed for an increase in the total commitments up to $160 million, subject to certain conditions and the satisfaction of specified financial covenants. The Credit Facility was amended on August 11, 2015 to increase the commitments and the accordion feature. The total commitments and accordion feature were $135 million and up to $250 million, respectively, subject to satisfaction of certain conditions at the time of any such future increase. As amended, the Credit Facility had a maturity date of August 11, 2020 and bore interest, at our election, at a rate per annum equal to (i) 2.25% plus the highest of a prime rate, the Federal Funds rate plus 0.5%, three month LIBOR plus 1%, and zero or (ii) 3.25% plus the one, three or six month LIBOR rate, as applicable.

On September 21, 2018, the Company amended certain provisions of the Credit Facility. Under the Amended Credit Agreement, (i) revolving commitments by lenders were reduced from $135 million to $115 million, with an accordion feature that allows for an increase in total commitments up to $180 million, subject to satisfaction of certain conditions at the time of any such future increase, (ii) the maturity date of the Credit Facility was extended to September 21, 2022 and the revolving period was extended to September 21, 2021, and (iii) borrowings under the Credit Facility bear interest, at the Company’s election, at a rate per annum equal to (a) 2.50% if the contribution to the borrowing base of eligible portfolio investments that are long-term U.S. government securities and first lien bank loans is greater than or equal to 70% (or 2.75% if such contribution is less than 70%) plus the one, three or six month LIBOR rate, as applicable, or (b) 1.50% if the contribution to the borrowing base of eligible portfolio investments that are long-term U.S. government securities and first lien bank loans is greater than or equal to 70% (or 1.75% if such contribution is less than 70%) plus the highest of (A) a prime rate, (B) the Federal Funds rate plus 0.5%, (C) three month LIBOR plus 1.0%, and (D) zero.

ALCENTRA CAPITAL CORPORATION AND SUBSIDIARY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)

June 30, 2019

(Unaudited)

The Amended Credit Agreement also modifies certain covenants in the Credit Facility, including to provide for a minimum asset coverage ratio of 2.00 to 1, a minimum interest coverage ratio of 2.00 to 1 as of the last day of any fiscal quarter, and a requirement to maintain stockholder’s equity as of the last day of any fiscal quarter to be no less than the greater of (i) 45% of the total assets of the Company and its subsidiaries as at the last day of such fiscal quarter and (ii) the sum of (x) $120,000,000 plus (y) 65% of the aggregate net proceeds of all sales of equity interests by the Company and its subsidiaries after the closing date of the Amended Credit Agreement. In addition, the Amended Credit Agreement requires payment of a commitment fee ranging from 0.5% to 1.0% per annum based on the size of the unused portion of the Credit Facility. This fee is included in interest expense on the Company’s Consolidated Statements of Operations. The Credit Facility is secured by a first priority security interest in all of our portfolio investments, the equity interests in certain of our direct and indirect subsidiaries, and substantially all of our other assets.

The Credit Facility agreement also contains customary terms and conditions, including, without limitation, affirmative and negative covenants, including, without limitation, information reporting requirements, a minimum liquidity test, and maintenance of RIC and BDC status. The Credit Facility agreement also contains customary events of default, including, without limitation, nonpayment, misrepresentation of representations and warranties in a material respect, breach of covenant, cross-default to other indebtedness, bankruptcy, and certain change in control events. As of June 30, 2019, the Company was in compliance in all material respects with the terms of the Credit Facility.

As of June 30, 2019 and December 31, 2018, the Company had United States dollar borrowings of $26.6 million and $28.5 million outstanding under the Credit Facility, respectively. For the three and six months ended June 30, 2019, the Company had average borrowings under the Credit Facility of $18.9 million and $24.6 million, respectively, with a weighted average interest rate of 4.29% and 4.58%, respectively. For the three and six months ended June 30, 2018, the Company had average borrowings under the Credit Facility of $58.4 million and $57.4 million, respectively, with a weighted average interest rate of 5.29% and 5.11%, respectively.

In accordance with the 1940 Act, during the three months ended March 31, 2019, the Company was allowed to borrow amounts such that its asset coverage, calculated pursuant to the 1940 Act, was at least 200% after such borrowing. On May 4, 2018, the Board, including a “required majority” (as such term is defined in Section 57(o) of the 1940 Act) of the Board, approved the application of the modified asset coverage requirements set forth in Section 61(a)(2) of the 1940 Act, as amended by the Small Business Credit Availability Act. As a result, effective on May 4, 2019, the Company’s asset coverage requirement applicable to senior securities, under the 1940 Act, was reduced to 150%; however, the Company remains subject to a 200% minimum asset coverage ratio covenant under the Credit Facility and thus will not be able to take advantage of the reduced asset coverage requirement under the 1940 Act unless and until it negotiates revised terms and conditions with the lenders under the Credit Facility. As of June 30, 2019, the aggregate amount outstanding of the senior securities issued by the Company was $26.6 million under The Credit Facility (also outstanding are the Alcentra Capital InterNotes® of $55.0 million) and the Company’s asset coverage was 274%.

11.

Market and Other Risk Factors

At June 30, 2019, a significant portion of the Company’s portfolio investments are comprised of non-publicly-traded securities. The non-publicly-traded securities trade in an illiquid marketplace. The portfolio is comprised of investments in the 17 industries listed in Note 13. Risks affecting these industries include, but are not limited to, increasing competition, rapid changes in technology, government actions and changes in economic conditions. These risk factors could have a material effect on the ultimate realizable value of the Company’s investments.

The Company estimates the fair value of investments for which observable market prices in active markets do not exist based on the best information available, which may differ significantly from values that would have otherwise been used had a ready market for the investments existed and the differences could be material.

Market conditions may deteriorate, which may negatively impact the estimated fair value of the Company’s investments or the amounts which are ultimately realized for such investments.

The above events are beyond the control of the Company and cannot be predicted. Furthermore, the ability to liquidate investments and realize value is subject to significant limitations and uncertainties. There may also be risk associated with the concentration of investments in one geographic region or in certain industries.

12.

Commitments and Contingencies

In the normal course of business, the Company enters into contracts that contain a variety of representations and warranties and which provide general indemnifications. In addition, the Company has agreed to indemnify its officers, directors, employees, agents or any person who serves on behalf of the Company from any loss, claim, damage, or liability which such person incurs by reason of his performance of activities of the Company, provided they acted in good faith. The Company expects the risk of loss related to its indemnifications to be remote.

ALCENTRA CAPITAL CORPORATION AND SUBSIDIARY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)

June 30, 2019

(Unaudited)

The Company’s investment portfolio may contain debt investments that are in the form of lines of credit and unfunded delayed draw commitments, which require the Company to provide funding when requested by portfolio companies in accordance with the terms of the underlying loan agreements. As of June 30, 2019 and December 31, 2018, the Company had $14.4 million and $15.0 million in unfunded commitments under loan and financing agreements, respectively. The Company’s unfunded commitment under loan and financing agreements as of June 30, 2019 and December 31, 2018 are presented below.

	As of
	June 30, 2019		December 31, 2018

BayMark Health Services, Inc.	$	4,000,000	$	-
Clanwilliam Group Ltd.		3,505,227		3,753,476
Epic Healthcare Staffing Intermediate Holdco, LLC		2,836,363		363,637
Manna Pro Products, LLC		2,589,092		92,764
Healthcare Associates of Texas, LLC		1,454,003		1,572,225
Pharmalogic Holdings Corp.		-		4,760,000
Superior Controls, Inc.		-		2,500,000
CGGR Operations Holding Corporation		-		2,000,000
Total	$	14,384,685	$	15,042,102

13.

Classification of Portfolio Investments

As of June 30, 2019, the Company’s portfolio investments were categorized as follows:

Investment Type	Cost		Fair Value		% of Net Assets*
Senior Secured - First Lien	$	137,153,769	$	135,524,154		95.48	%
Senior Secured - Second Lien		64,856,841		65,239,620		45.97	%
Equity/Other		30,888,997		15,389,916		10.84	%
CLO/Structured Credit		1,949,886		1,828,490		1.29	%
Senior Subordinated		4,754,007		1,225,020		0.86	%
Total	$	239,603,500	$	219,207,200		154.44	%

Geographic Region
South	$	47,377,522	$	46,345,318		32.65	%
West		33,412,457		33,455,553		23.57	%
Midwest		33,896,464		32,146,637		22.65	%
Southeast		42,533,288		31,823,914		22.42	%
Northeast		30,730,520		26,518,960		18.68	%
Mid-Atlantic		28,674,664		25,960,951		18.29	%
Canada		14,457,969		14,567,996		10.27	%
Ireland		6,570,730		6,559,381		4.62	%
US (CLO)		1,949,886		1,828,490		1.29	%
Total	$	239,603,500	$	219,207,200		154.44	%

Industry
Business Services	$	46,855,927	$	47,002,952		33.12	%
Healthcare Services		44,373,007		44,545,329		31.38	%
Consumer Services		33,419,981		32,968,796		23.23	%
High Tech Industries		18,535,483		18,654,396		13.14	%
Industrial Services		20,298,185		16,372,678		11.54	%
Technology & Telecom		13,172,751		13,233,217		9.32	%
Oil & Gas Services		10,955,419		10,955,419		7.72	%
Media: Advertising, Printing & Publishing		12,677,834		8,679,689		6.12	%
Financial Services		8,244,193		8,619,188		6.07	%
Environmental/Recycling Services		6,953,565		5,098,537		3.59	%
Telecommunications		4,414,967		4,417,330		3.11	%
Retail		4,816,914		4,346,403		3.06	%
USD CLO		1,949,886		1,828,490		1.29	%
Security		5,485,400		1,023,603		0.72	%
Transportation Logistics		1,254,000		795,212		0.56	%
Industrial Manufacturing		500,000		665,961		0.47	%
Education		5,695,988		—		0.00	%
Total	$	239,603,500	$	219,207,200		154.44	%

*Fair value as a percentage of Net Assets

ALCENTRA CAPITAL CORPORATION AND SUBSIDIARY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)

June 30, 2019

(Unaudited)

As of December 31, 2018, the Company’s portfolio investments were categorized as follows:

Investment Type	Cost		Fair Value		% of Net Assets*
Senior Secured - First Lien	$	167,745,286	$	168,154,929		115.33	%
Senior Secured - Second Lien		42,210,313		42,549,396		29.18	%
Equity/Other		37,232,929		21,141,117		14.50	%
CLO/Structured Credit		1,948,058		1,739,600		1.20	%
Senior Subordinated		4,741,760		1,212,774		0.83	%
Total	$	253,878,346	$	234,797,816		161.04	%

Geographic Region
West	$	52,427,327	$	54,266,593		37.22	%
Southeast		56,535,014		44,026,689		30.20	%
South		45,437,808		43,758,859		30.01	%
Northeast		43,622,806		38,144,071		26.16	%
Midwest		24,841,625		23,614,916		16.20	%
Canada		22,721,398		22,900,000		15.71	%
Ireland		6,344,310		6,347,088		4.35	%
US		1,948,058		1,739,600		1.19	%
Total	$	253,878,346	$	234,797,816		161.04	%

Industry
Business Services	$	45,913,805	$	46,130,114		31.64	%
Healthcare Services		44,727,905		45,038,816		30.89	%
Technology & Telecom		32,324,555		33,345,749		22.87	%
Consumer Services		26,231,367		26,237,699		17.99	%
Industrial Services		21,095,416		19,559,789		13.42	%
Retail		12,051,199		12,119,708		8.31	%
Oil & Gas Services		11,385,108		11,382,254		7.81	%
Wholesale/Distribution		10,189,394		10,614,192		7.28	%
High Tech Industries		8,701,223		8,729,396		5.99	%
Media: Advertising, Printing & Publishing		12,677,834		6,554,225		4.50	%
Environmental/Recycling Services		6,757,790		5,699,791		3.91	%
Telecommunications		4,410,000		4,410,000		3.02	%
USD CLO		1,948,058		1,739,600		1.19	%
Security		5,485,401		1,023,999		0.70	%
Waste Services		2,529,303		820,437		0.56	%
Transportation Logistics		1,254,000		726,000		0.50	%
Industrial Manufacturing		500,000		666,047		0.46	%
Education		5,695,988		-		0.00	%
Total	$	253,878,346	$	234,797,816		161.04	%

*Fair value as a percentage of Net Assets

ALCENTRA CAPITAL CORPORATION AND SUBSIDIARY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)

June 30, 2019

(Unaudited)

14.

Financial Highlights

The following per share data and financial ratios have been derived from information provided in the consolidated financial statements of the Company. The following is a schedule of financial highlights for one share of common stock for the six months ended June 30, 2019 and June 30, 2018.

	For the six months ended			For the six months ended
	June 30, 2019			June 30, 2018
	(Unaudited)			(Unaudited)
Per share data⁽¹⁾
Net asset value, beginning of period	$	11.13		$	11.09

Net investment income (loss)		0.42			0.52
Net realized and unrealized gains (losses)⁽²⁾		0.07			(0.31	)
Benefit (Provision) for income taxes on unrealized gain (loss) on investments		(0.09	)		0.07
Net increase (decrease) in net assets resulting from operations		0.40			0.28

Distributions to shareholders:⁽³⁾
From net investment income		(0.51	)		(0.36	)
Total dividend distributions declared⁽⁷⁾		(0.51	)		(0.36	)

Net asset value, end of period	$	11.02		$	11.01
Market value per share, end of period	$	8.38		$	6.39

Total return based on net asset value⁽⁴⁾⁽⁵⁾		3.6	%		2.5	%
Total return based on market value⁽⁴⁾⁽⁵⁾		37.4	%		(19.5	)%

Shares outstanding at end of period		12,875,566			13,582,751

Ratio/Supplemental Data:
Net assets, at end of period	$	141,937,995		$	149,594,744
Ratio of total expenses before waiver to average net assets⁽⁶⁾		10.25	%		10.47	%
Ratio of interest expenses to average net assets⁽⁶⁾		4.42	%		4.75	%
Ratio of incentive fees to average net assets⁽⁶⁾		(0.97	)%		—	%
Ratio of waiver of management and incentive fees to average net assets⁽⁶⁾		0.40	%		0.14	%
Ratio of net expenses to average net assets⁽⁶⁾		9.86	%		10.33	%
Ratio of net investment income (loss) before waiver to average net assets⁽⁶⁾		7.36	%		9.63	%
Ratio of net investment income (loss) after waiver to average net assets⁽⁶⁾		6.96	%		9.49	%

Total Credit Facility payable outstanding	$	26,565,008		$	58,553,273
Total Notes payable outstanding	$	55,000,000		$	55,000,000

Asset coverage ratio⁽⁷⁾		2.7			2.3
Portfolio turnover rate⁽⁵⁾		27	%		16	%

(1)

The per share data was derived by using the average shares outstanding during the period.

(2)

The amount shown at this caption is the balancing figure derived from the other figures in the schedule. The amount shown at this caption for a share outstanding throughout the year may not agree with the change in the aggregate gains and losses in portfolio securities for the year because of the timing of purchases or sales of the Company's shares in relation to fluctuating market values for the portfolio.

(3)

The per share data for distributions is the actual amount of distributions paid or payable per share of common stock outstanding during the entire period.

(4)

Returns are historical and are calculated by determining the percentage change in net asset value or market value with all distributions reinvested. Distributions are assumed to be reinvested at prices obtained under the Company’s dividend reinvestment plan.

(5)

Not annualized.

(6)

Annualized, except for consulting fees.

(7)

Includes a special dividend of $0.15 per share paid to stockholders of record as of June 28, 2019.

ALCENTRA CAPITAL CORPORATION AND SUBSIDIARY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)

June 30, 2019

(Unaudited)

(6)

Annualized, except for non-recurring expenses.

(7)

Asset coverage ratio is equal to (i) the sum of (A) net assets at the end of the period and (B) debt outstanding at the end of the period, divided by (ii) total debt outstanding at the end of the period.

15.

Unconsolidated Significant Subsidiaries

In accordance with the SEC’s Regulation S-X and GAAP, the Company has one subsidiary, Southern Technical College (“STI”), that is deemed to be a “significant subsidiary” as of and for the six months ended June 30, 2019 and two subsidiaries, FST Technical Services, LLC ("FST") and STI, that are deemed to be "significant subsidiaries" as of and for the year ended December 31, 2018 for which summarized financial information is presented below as of and for the six months ended June 30, 2019 and as of and for the year ended December 31, 2018 in aggregate.

Southern Technical College

	As of			For the six months ended
Balance Sheet	June 30, 2019		Income Statement	June 30, 2019

Current Assets	$	6,496,255	Net Sales	$	10,708,883
Noncurrent Assets		43,646,754	Gross Profit		1,779,926
Current Liabilities		8,273,232	Net Income/EBITDA		1,798,415
Noncurrent Liabilities		18,458,702

Southern Technical College and FST Technical Services, LLC

	As of			For the year ended
Balance Sheet	December 31, 2018		Income Statement	December 31, 2018

Current Assets	$	15,536,556	Net Sales	$	50,355,783
Noncurrent Assets		64,090,276	Gross Profit		12,732,260
Current Liabilities		10,838,139	Net Income/EBITDA		7,318,579
Noncurrent Liabilities		32,322,997

In addition to the risks associated with our investments in general, there are unique risks associated with our investments in these entities. The business and growth of FST at December 31, 2018 depended in large part on the continued trend toward outsourcing of certain services in the semiconductor and biopharmaceutical industries and there was no assurance that this trend in outsourcing would have continued, as companies may elect to perform such services internally. A significant change in the direction of that trend generally, or a trend in the semiconductor and biopharmaceutical industry not to use, or to reduce the use of, outsourced services such as those provided by FST, could have significantly decreased its revenues and such decreased revenues could have had a material adverse effect on it or its results of operations or financial condition. The Company sold its investment in FST on February 8, 2019.

The business and growth of STI have been impacted by regulatory changes that have affected for-profit institutions. Although the regulatory climate has since improved, there is no assurance that this will continue to improve enrollment or retention rates.

16.

Subsequent Events

Subsequent to June 30, 2019, the following activity occurred:

On July 3, 2019, the Company paid a quarterly dividend of $0.18 per share and a special dividend of $0.15 per share to stockholders of record as of June 28, 2019.

On August 5, 2019, the Board approved the 2019 third quarter dividend of $0.18 per share for stockholders of record as of September 26, 2019, payable on October 3, 2019.

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations Forward-Looking Statements

Some of the statements in this quarterly report on Form 10-Q constitute forward-looking statements, which relate to future events or our future performance or financial condition. The forward-looking statements contained in this quarterly report on Form 10-Q involve risks and uncertainties, including statements as to:

our future operating results, including the performance of our existing investments;

the introduction, withdrawal, success and timing of business initiatives and strategies;

changes in political, economic or industry conditions, the interest rate environment or financial and capital markets, which could result in changes in the value of our assets;

the relative and absolute investment performance and operations of our investment adviser;

the impact of increased competition;

the impact of investments we intend to make and future acquisitions and divestitures;

our ability to turn potential investment opportunities into transactions and thereafter into completed and successful investments;

the unfavorable resolution of any future legal proceedings;

our business prospects and the prospects of our portfolio companies;

our regulatory structure and tax status;

the adequacy of our cash resources and working capital;

the timing of cash flows, if any, from the operations of our portfolio companies;

the impact of interest rate volatility on our results, particularly because we use leverage as part of our investment strategy;

the ability of our portfolio companies to achieve their objective;

the impact of legislative and regulatory actions and reforms and regulatory, supervisory or enforcement actions of government agencies relating to us or our investment adviser;

the impact of activist stockholder activities and the strategic alternative review process being undertaken by the Committee of Independent Directors of our Board of Directors (the “Board”) on our professional and consulting fees and expenses and on management distractions;

our contractual arrangements and relationships with third parties;

our ability to access capital and any future financings by us;

the ability of our investment adviser to attract and retain highly talented professionals; and

the impact of changes to tax legislation and, generally, our tax position.

Such forward-looking statements may include statements preceded by, followed by or that otherwise include the words “may,” “might,” “will,” “intend,” “should,” “could,” “can,” “would,” “expect,” “believe,” “estimate,” “anticipate,” “predict,” “potential,” “plan” or similar words.

We have based the forward-looking statements included in this quarterly report on Form 10-Q on information available to us on the date of this quarterly report on Form 10-Q, and we assume no obligation to update any such forward-looking statements. Actual results could differ materially from those anticipated in our forward-looking statements, and future results could differ materially from historical performance. We undertake no obligation to revise or update any forward-looking statements, whether as a result of new information, future events or otherwise, unless required by law or SEC rule or regulation. You are advised to consult any additional disclosures that we may make directly to you or through reports that we in the future may file with the SEC, including annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K.

The following analysis of our financial condition and results of operations should be read in conjunction with our consolidated financial statements and the related notes thereto contained elsewhere in this quarterly report on Form 10-Q.

Overview

Alcentra Capital Corporation (the “Company”, “Alcentra”, “we”, “us” or “our”) was formed as a Maryland corporation in 2013 as an externally managed, non-diversified closed-end management investment company that has elected to be regulated as a business development company under the Investment Company Act of 1940, as amended (the “1940 Act”). Alcentra is managed by Alcentra NY, LLC (the “Adviser”, or “Alcentra NY”), a registered investment adviser under the Investment Advisers Act of 1940, as amended (the “Advisers Act”). State Street Bank and Trust Company (“State Street”) provides us with financial reporting, post-trade compliance, and treasury services. In addition, for U.S. federal income tax purposes,

10-Q	2019-06-30	Quarter: 2019-06-30
10-Q	2019-03-31	Quarter: 2019-03-31
10-K	2018-12-31	Annual: 2018-12-31
10-Q	2018-09-30	Quarter: 2018-09-30
10-Q	2018-06-30	Quarter: 2018-06-30
10-Q	2018-03-31	Quarter: 2018-03-31
10-K	2017-12-31	Annual: 2017-12-31
10-Q	2017-09-30	Quarter: 2017-09-30
10-Q	2017-06-30	Quarter: 2017-06-30
10-Q	2017-03-31	Quarter: 2017-03-31
10-K	2016-12-31	Annual: 2016-12-31
10-Q	2016-09-30	Quarter: 2016-09-30
10-Q	2016-06-30	Quarter: 2016-06-30
10-Q	2016-03-31	Quarter: 2016-03-31
10-K	2015-12-31	Annual: 2015-12-31
10-Q	2015-09-30	Quarter: 2015-09-30
10-Q	2015-06-30	Quarter: 2015-06-30
10-Q	2015-03-31	Quarter: 2015-03-31
10-K	2014-12-31	Annual: 2014-12-31
10-Q	2014-09-30	Quarter: 2014-09-30
10-Q	2014-06-30	Quarter: 2014-06-30
10-Q	2014-03-31	Quarter: 2014-03-31

8-K	2019-08-12	Enter Agreement, Regulation FD, Exhibits
8-K	2019-04-04	Other Events, Exhibits
8-K	2019-03-11	Earnings, Exhibits
8-K	2019-01-14	Earnings, Exhibits
8-K	2018-12-11	Other Events, Exhibits
8-K	2018-09-21	Enter Agreement, Off-BS Arrangement, Exhibits
8-K	2018-09-16	Officers
8-K	2018-06-26	Shareholder Vote
8-K	2018-06-19	Officers
8-K	2018-01-04	Officers, Other Events, Exhibits

MITT	AG Mortgage Investment Trust	504
USAU	US Gold	17
TSLX	TPG Specialty Lending	0
DUSA	Dusa Pharmaceuticals	0
CPTA	Capitala Finance	0
GARS	Garrison Capital	0
SAB	Grupo Casa Saba	0
RA	Railamerica	0
ARCC	Ares Capital	0
TPVG	Triplepoint Venture Growth Bdc	0

EX-31.1	tv526738_ex31-1.htm
EX-31.2	tv526738_ex31-2.htm
EX-32.1	tv526738_ex32-1.htm
EX-32.2	tv526738_ex32-2.htm